<SEC-DOCUMENT>0001193125-25-205061.txt : 20250916
<SEC-HEADER>0001193125-25-205061.hdr.sgml : 20250916
<ACCEPTANCE-DATETIME>20250916164116
ACCESSION NUMBER:		0001193125-25-205061
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250915
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250916
DATE AS OF CHANGE:		20250916

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medtronic plc
		CENTRAL INDEX KEY:			0001613103
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		FISCAL YEAR END:			0424

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36820
		FILM NUMBER:		251317782

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		BUILDING TWO PARKMORE BUSINESS PARK WEST
		CITY:			GALWAY
		PROVINCE COUNTRY:   	L2
		ZIP:			H91 4K49
		BUSINESS PHONE:		01135314381700

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		BUILDING TWO PARKMORE BUSINESS PARK WEST
		CITY:			GALWAY
		PROVINCE COUNTRY:   	L2
		ZIP:			H91 4K49

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Ltd
		DATE OF NAME CHANGE:	20150112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Holdings Ltd
		DATE OF NAME CHANGE:	20140711

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kalani I Ltd
		DATE OF NAME CHANGE:	20140709
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d34781d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdt="http://www.medtronic.com/20250915" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2025-09-15_to_2025-09-15" name="dei:EntityCentralIndexKey" contextRef="duration_2025-09-15_to_2025-09-15">0001613103</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityAddressPostalZipCode_duration_2025-09-15_to_2025-09-15" name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-09-15_to_2025-09-15">H91 VY19</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2025-09-15_to_2025-09-15" name="dei:AmendmentFlag" contextRef="duration_2025-09-15_to_2025-09-15">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="mdt-20250915.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-09-15_to_2025-09-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A0.000SeniorNotesDue2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A2.625SeniorNotesDue2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.125SeniorNotesDue2027Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A0.375SeniorNotesDue2028Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.000SeniorNotesDue2028Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.650SeniorNotesDue2029Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.625SeniorNotesDue2031Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.000SeniorNotesDue2031Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.125SeniorNotesDue2031Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A0.750SeniorNotesDue2032Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.375SeniorNotesDue2034Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.875SeniorNotesDue2036Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A2.250SeniorNotesDue2039Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.500SeniorNotesDue2039Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.375SeniorNotesDue2040Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A4.150SeniorNotesDue2043Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.750SeniorNotesDue2049Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.625SeniorNotesDue2050Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A4.150SeniorNotesDue2053Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-15</xbrli:startDate> <xbrli:endDate>2025-09-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-09-15_to_2025-09-15" id="Fact_1">8-K</ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p><p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-09-15_to_2025-09-15" format="ixt:date-monthname-day-year-en" id="Fact_0">September 15, 2025</ix:nonNumeric></p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityRegistrantName" id="ixv-557">Medtronic plc</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in its Charter)</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="ixv-558">Ireland</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityFileNumber" id="ixv-559">1-36820</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityTaxIdentificationNumber" id="ixv-560">98-1183488</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityAddressAddressLine1" id="ixv-561">Building Two</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityAddressAddressLine2" id="ixv-562">Parkmore Business Park West</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityAddressCityOrTown" id="ixv-563">Galway</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="ixv-564">Ireland</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)</p><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">+<ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:CountryRegion" id="ixv-565">353</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:CityAreaCode" id="ixv-566">1</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:LocalPhoneNumber" id="ixv-567">438-1700</ix:nonNumeric></span></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:WrittenCommunications" format="ixt:fixed-false" id="ixv-568">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="ixv-569">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="ixv-570">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="ixv-571">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:Security12bTitle" id="ixv-572">Ordinary shares, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:TradingSymbol" id="ixv-573">MDT</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-574">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member" name="dei:Security12bTitle" id="ixv-575">0.000% Senior Notes due 2025</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member" name="dei:TradingSymbol" id="ixv-576">MDT/25A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-577">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member" name="dei:Security12bTitle" id="ixv-578">2.625% Senior Notes due 2025</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member" name="dei:TradingSymbol" id="ixv-579">MDT/25B</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-580">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member" name="dei:Security12bTitle" id="ixv-581">1.125% Senior Notes due 2027</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member" name="dei:TradingSymbol" id="ixv-582">MDT/27</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-583">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member" name="dei:Security12bTitle" id="ixv-584">0.375% Senior Notes due 2028</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member" name="dei:TradingSymbol" id="ixv-585">MDT/28</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-586">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member" name="dei:Security12bTitle" id="ixv-587">3.000% Senior Notes due 2028</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member" name="dei:TradingSymbol" id="ixv-588">MDT/28A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-589">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member" name="dei:Security12bTitle" id="ixv-590">3.650% Senior Notes due 2029</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member" name="dei:TradingSymbol" id="ixv-591">MDT/29</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-592">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member" name="dei:Security12bTitle" id="ixv-593">1.625% Senior Notes due 2031</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member" name="dei:TradingSymbol" id="ixv-594">MDT/31</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-595">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member" name="dei:Security12bTitle" id="ixv-596">1.000% Senior Notes due 2031</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member" name="dei:TradingSymbol" id="ixv-597">MDT/31A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-598">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member" name="dei:Security12bTitle" id="ixv-599">3.125% Senior Notes due 2031</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member" name="dei:TradingSymbol" id="ixv-600">MDT/31B</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-601">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member" name="dei:Security12bTitle" id="ixv-602">0.750% Senior Notes due 2032</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member" name="dei:TradingSymbol" id="ixv-603">MDT/32</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-604">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member" name="dei:Security12bTitle" id="ixv-605">3.375% Senior Notes due 2034</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member" name="dei:TradingSymbol" id="ixv-606">MDT/34</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-607">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member" name="dei:Security12bTitle" id="ixv-608">3.875% Senior Notes due 2036</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member" name="dei:TradingSymbol" id="ixv-609">MDT/36</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-610">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member" name="dei:Security12bTitle" id="ixv-611">2.250% Senior Notes due 2039</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member" name="dei:TradingSymbol" id="ixv-612">MDT/39A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-613">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member" name="dei:Security12bTitle" id="ixv-614">1.500% Senior Notes due 2039</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member" name="dei:TradingSymbol" id="ixv-615">MDT/39B</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-616">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member" name="dei:Security12bTitle" id="ixv-617">1.375% Senior Notes due 2040</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member" name="dei:TradingSymbol" id="ixv-618">MDT/40A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-619">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member" name="dei:Security12bTitle" id="ixv-620">4.150% Senior Notes due 2043</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member" name="dei:TradingSymbol" id="ixv-621">MDT/43A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-622">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member" name="dei:Security12bTitle" id="ixv-623">1.750% Senior Notes due 2049</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member" name="dei:TradingSymbol" id="ixv-624">MDT/49</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-625">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member" name="dei:Security12bTitle" id="ixv-626">1.625% Senior Notes due 2050</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member" name="dei:TradingSymbol" id="ixv-627">MDT/50</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-628">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member" name="dei:Security12bTitle" id="ixv-629">4.150% Senior Notes due 2053</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member" name="dei:TradingSymbol" id="ixv-630">MDT/53</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-631">New York Stock Exchange</ix:nonNumeric></td></tr> </table><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric contextRef="duration_2025-09-15_to_2025-09-15" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="ixv-632">&#9744;</ix:nonNumeric></p><p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;7.01.</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure.</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;15, 2025, Medtronic public limited company (&#8220;Medtronic plc&#8221;) issued a press release announcing the pricing of the Offering (as defined below), the net proceeds of which are expected to be used to repay Medtronic Global Holdings S.C.A.&#8217;s (&#8220;Medtronic Luxco&#8221;) 0.000% Senior Notes due 2025 and Medtronic Luxco&#8217;s 2.625% Senior Notes due 2025. The financial impact from the Offering and the expected use of proceeds was reflected in Medtronic plc&#8217;s fiscal year 2026 adjusted earnings per share guidance that Medtronic plc reiterated on August&#160;19, 2025.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01.</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events.</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Underwriting Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;15, 2025, Medtronic, Inc., Medtronic plc and Medtronic Luxco entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with the underwriters listed therein, for which Deutsche Bank AG, London Branch and Goldman Sachs&#160;&amp; Co. LLC acted as representatives. Pursuant to the Underwriting Agreement, Medtronic, Inc., an indirect wholly owned subsidiary of Medtronic plc, will issue and sell &#8364;750,000,000 aggregate principal amount of its 2.950% Senior Notes due 2030 (the &#8220;2030 Notes&#8221;) and &#8364;750,000,000 aggregate principal amount of its 4.200% Senior Notes due 2045 (the &#8220;2045 Notes&#8221; and together with the 2030 Notes, the &#8220;Notes&#8221;) to the underwriters, in an underwritten offering (the &#8220;Offering&#8221;) pursuant to a registration statement on Form <span style="white-space:nowrap">S-3</span> (the &#8220;Registration Statement&#8221;) (File <span style="white-space:nowrap">No.&#160;333-270272)</span> filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on March&#160;3, 2023, and a preliminary prospectus supplement and prospectus supplement filed with the Commission related to the Offering. The Notes are fully and unconditionally guaranteed on a joint and several basis by Medtronic Luxco and Medtronic plc.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Underwriting Agreement is attached hereto as Exhibit 1.1 and is incorporated by reference into the Registration Statement. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Redemption of Existing Notes </span></p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;16, 2025, Medtronic Luxco elected to redeem all &#8364;500,000,000 of its outstanding 2.625% Senior Notes due 2025 (CUSIP&#160;Number:&#160;58507L AX7) (the &#8220;Redemption Notes&#8221;), on September 29, 2025 (the &#8220;Redemption Date&#8221;). The Redemption Notes will be redeemed at a redemption price equal to 100% of the principal amount of the Redemption Notes to be redeemed, plus accrued and unpaid interest to, but not including, the Redemption Date. Medtronic Luxco&#8217;s obligation to redeem the Redemption Notes is conditioned upon the completion of the issuance and sale of the Notes on or before the Redemption Date (which Redemption Date could be delayed in Medtronic Luxco&#8217;s sole discretion if this condition is not satisfied pursuant to the terms of the indenture governing the Redemption Notes).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Medtronic Luxco has given notice to Computershare Trust Company, N.A., as the trustee (the &#8220;Trustee&#8221;) and U.S. Bank Europe DAC, as the paying agent (the &#8220;Paying Agent&#8221;), for the Redemption Notes, instructing the Paying Agent to distribute a notice of redemption to all registered holders of the Redemption Notes on September&#160;17, 2025. Copies of such notice of redemption and additional information relating to the procedure for redemption of the Redemption Notes may be obtained from the Paying Agent.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this Current Report on Form <span style="white-space:nowrap">8-K</span> does not constitute a notice of redemption of the Redemption Notes. Holders of the Redemption Notes should refer to the notice of redemption to be delivered by the Paying Agent to the registered holders of the Redemption Notes.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Exhibits.</p></td></tr> </table><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Exhibit</span> <br/><span style="font-weight:bold">Number</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d34781dex11.htm">Underwriting Agreement, dated as of September&#160;15, 2025, among Medtronic, Inc., Medtronic plc and Medtronic Global Holdings S.C.A., and Deutsche Bank AG, London Branch and Goldman Sachs&#160;&amp; Co. LLC as representatives of the several underwriters named therein. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded with the Inline XBRL document).</td></tr> </table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">
<tr>
<td style="width:46%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>
<td style="vertical-align:bottom"/>
<td style="width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">MEDTRONIC PUBLIC LIMITED COMPANY</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thierry Pi&#233;ton</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: September&#160;16, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Thierry Pi&#233;ton</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President and Chief Financial Officer</td></tr></table></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d34781dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>Execution Version </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">UNDERWRITING AGREEMENT </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#128;1,500,000,000 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MEDTRONIC,
INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.950% Senior Notes due 2030 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4.200% Senior Notes due 2045 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Underwriting Agreement </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">September&nbsp;15, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deutsche Bank AG, London
Branch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Deutsche Bank
AG, London Branch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">21 Moorfields </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">London EC2Y 9DB </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United Kingdom </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Goldman Sachs&nbsp;&amp; Co. LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 West Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10282 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>as Representatives of the
several Underwriters </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Medtronic, Inc., a Minnesota corporation (the &#8220;Company&#8221;), proposes to issue and sell to the several Underwriters listed in Schedule
I hereto (the &#8220;Underwriters&#8221;), for whom Deutsche Bank AG, London Branch and Goldman Sachs&nbsp;&amp; Co. LLC are acting as representatives (the &#8220;Representatives&#8221;), &#128;750,000,000 principal amount of its 2.950% Senior Notes
due 2030 (the &#8220;2030 Notes&#8221;) and &#128;750,000,000 principal amount of its 4.200% Senior Notes due 2045 (the &#8220;2045 Notes&#8221; and together with the 2030 Notes, the &#8220;Securities&#8221;). The Securities will be issued pursuant
to the Indenture dated as of December&nbsp;10, 2014 between the Company and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (the &#8220;Trustee&#8221;), as supplemented by the second
supplemental indenture dated as of January&nbsp;26, 2015 between Medtronic Public Limited Company, a company incorporated under the laws of Ireland (&#8220;Parent&#8221;) and the Trustee, as supplemented by the third supplemental indenture dated as
of January&nbsp;26, 2015 between Medtronic Global Holdings S.C.A., a corporate </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
partnership limited by shares (<I>soci&eacute;t&eacute; en commandite par actions</I>), incorporated and existing under the laws of the Grand Duchy of Luxembourg (&#8220;Medtronic Global&#8221;)
and the Trustee, as supplemented by the fourth supplemental indenture dated as of February&nbsp;22, 2023 between the Company and the Trustee, as supplemented by the fifth supplemental indenture dated as of June&nbsp;3, 2024 among the Company,
Parent, Medtronic Global, the Trustee and U.S. Bank Europe DAC, UK Branch (formerly known as Elavon Financial Services DAC, UK Branch) (&#8220;Paying Agent&#8221;) (such indenture as supplemented, the &#8220;Base Indenture&#8221;), as further
supplemented by a supplemental indenture to be dated the Closing Date (as defined below) (the &#8220;Sixth Supplemental Indenture&#8221; and, together with the Base Indenture, the &#8220;Indenture&#8221;) among the Company, Parent, Medtronic Global,
the Trustee and Paying Agent. Each of Parent and Medtronic Global (together, the &#8220;Guarantors&#8221;), will fully and unconditionally guarantee the Securities on a senior unsecured basis (the &#8220;Guarantees&#8221;). In connection with the
issuance of the Securities, the Company will enter into an Agency Agreement (the &#8220;Agency Agreement&#8221;) with Paying Agent, to be dated as of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and the Guarantors hereby confirm their agreement with the several Underwriters concerning the purchase and sale of the
Securities, as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>. The Company and the Guarantors have prepared and filed with the Securities and
Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;Securities Act&#8221;), a registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-270272),</FONT> including a prospectus (the &#8220;Base Prospectus&#8221;), relating to debt securities to be issued from time to time by the Company. The
Company and the Guarantors have also filed, or propose to file, with the Commission pursuant to Rule 424 under the Securities Act a prospectus supplement specifically relating to the Securities (the &#8220;Prospectus Supplement&#8221;). The
registration statement, as amended at the time it becomes effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness
(&#8220;Rule 430 Information&#8221;), is referred to herein as the &#8220;Registration Statement&#8221;; and as used herein, the term &#8220;Prospectus&#8221; means the Base Prospectus as supplemented by the Prospectus Supplement specifically
relating to the Securities in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Securities and the term &#8220;Preliminary
Prospectus&#8221; means the preliminary Prospectus Supplement specifically relating to the Securities together with the Base Prospectus. Any reference in this underwriting agreement (the &#8220;Agreement&#8221;) to the Registration Statement, any
Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, as of the effective
date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be and any reference to &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;Exchange Act&#8221;) that are deemed to be incorporated by reference
therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to the time when sales of the Securities were first made (the &#8220;Time of Sale&#8221;), the Company has prepared certain
information which information is identified in Annex A of this Agreement (collectively, the &#8220;Time of Sale Information&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.
<U>Purchase and Sale of the Securities</U>. (a)&nbsp;The Company agrees to issue and sell the Securities to the several Underwriters as provided in this Agreement, and each Underwriter, on the basis of the representations, warranties and agreements
set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the Company the respective principal amount of Securities set forth opposite such Underwriter&#8217;s name in Schedule I hereto at a
price equal to: (i) 99.624% of the principal amount of 2030 Notes, plus accrued interest, if any, from September&nbsp;29, 2025 to the Closing Date and (ii) 99.247% of the principal amount of 2045 Notes, plus accrued interest, if any, from
September&nbsp;29, 2025 to the Closing Date. The Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company understands that the Underwriters intend to make a public offering of the Securities as soon after the effectiveness of this
Agreement as in the judgment of the Representatives is advisable, and initially to offer the Securities on the terms set forth in the Prospectus. The Company acknowledges and agrees that the Underwriters may offer and sell Securities to or through
any affiliate of an Underwriter and that any such affiliate may offer and sell Securities purchased by it to or through any Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for and delivery of the Securities will be made at the offices of Davis Polk&nbsp;&amp; Wardwell LLP, 450 Lexington Avenue, New
York, New York 10017 at 10:00 A.M., London time, on September 29, 2025, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree upon in
writing. The time and date of such payment and delivery is referred to herein as the &#8220;Closing Date.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Payment for the
Securities shall be made by wire transfer in immediately available funds to the account(s) specified by the Company to the Representatives against delivery of the Securities in book-entry form through a common depositary for Clearstream Banking,
S.A. (&#8220;Clearstream&#8221;) and Euroclear Bank S.A./N.V. (&#8220;Euroclear&#8221;), for the account of the Underwriters, of one or more global notes representing the Securities (collectively, the &#8220;Global Note&#8221;), with any transfer
taxes payable in connection with the sale of the Securities duly paid by the Company. The Global Note will be made available for inspection by the Representatives not later than 1:00 P.M., London time, on the business day prior to the Closing Date.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company and the Guarantors acknowledge and agree that the Underwriters are acting
solely in the capacity of an arm&#8217;s length contractual counterparty to the Company and the Guarantors with respect to the offering of Securities contemplated hereby (including in connection with determining the terms of the offering) and not as
a financial advisor or a fiduciary to, or an agent of, the Company, the Guarantors or any other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company, the Guarantors or any other person as to any legal,
tax, investment, accounting or regulatory matters in any jurisdiction. The Company and the Guarantors shall consult with their own advisors concerning such matters and shall be responsible for making their own independent investigation and appraisal
of the transactions contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company or the Guarantors with respect thereto. Any review by the Underwriters of the Company, the Guarantors, the transactions
contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company or the Guarantors or any other person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Goldman Sachs&nbsp;&amp; Co. LLC acknowledges that the Securities represented by the Global Notes will initially be credited to an account
(the &#8220;Commissionaire Account&#8221;) for the benefit of Goldman Sachs&nbsp;&amp; Co. LLC, the terms of which include a third-party beneficiary clause (&#8216;<I>stipulation</I> <I>pour</I> <I>autrui&#8217;</I>) with the Company as the
third-party beneficiary and provide that such Global Notes are to be delivered to others only against payment of the net proceeds for the Securities into the Commissionaire Account on a delivery against payment basis. Goldman Sachs&nbsp;&amp; Co.
LLC acknowledges that (i)&nbsp;the Securities represented by the Global Notes shall be held to the order of the Company as set out above and (ii)&nbsp;the net proceeds for the Securities received in the Commissionaire Account will be held on behalf
of the Company until such time as they are transferred to the Company&#8217;s order. Goldman Sachs&nbsp;&amp; Co. LLC undertakes that the net proceeds for the Securities will be transferred to the Company&#8217;s order promptly following receipt of
such proceeds in the Commissionaire Account. The Company acknowledges and accepts the benefit of the third-party beneficiary clause (&#8216;<I>stipulation</I> <I>pour</I> <I>autrui&#8217;</I>) pursuant to the Civil Code of Belgium and Luxembourg, as
applicable, in respect of the Commissionaire Account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and Warranties of the Company and the Guarantors</U>. The
Company and each of the Guarantors, jointly and severally, represent and warrant to each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Preliminary
Prospectus.</I> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of filing thereof, complied in all material respects with the Securities Act and
did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
misleading; <U>provided</U> that the Company and each of the Guarantors makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity
with information relating to any Underwriter furnished to the Company and the Guarantors in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Time of Sale Information</I>. The Time of Sale Information, at the Time of Sale did not, and at the Closing Date will not, contain any
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that none of the Company nor any
Guarantor makes any representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company and the Guarantors in writing by such
Underwriter through the Representatives expressly for use in such Time of Sale Information. No statement of material fact included in the Prospectus has been omitted from the Time of Sale Information and no statement of material fact included in the
Time of Sale Information that is required to be included in the Prospectus has been omitted therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Issuer</I> <I>Free Writing
Prospectus. </I>The Company and the Guarantors (including their agents and representatives, other than the Underwriters in their capacity as such) have not prepared, made, used, authorized, approved or referred to and will not prepare, make, use,
authorize, approve or refer to any &#8220;written communication&#8221; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company, the
Guarantors or their agents and representatives (other than a communication referred to in clauses (i), (ii), (iii) and (iv)&nbsp;below) an &#8220;Issuer Free Writing Prospectus&#8221;) other than (i)&nbsp;any document not constituting a prospectus
pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act, (ii)&nbsp;the Registration Statement, (iii)&nbsp;the Preliminary Prospectus, (iv)&nbsp;the Prospectus, (v)&nbsp;the documents listed on Annex A hereto
as constituting the Time of Sale Information and (vi)&nbsp;any electronic road show or any other written communications, in each case approved in writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complied in all
material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus
accompanying, or delivered prior to delivery of, such Issuer Free Writing Prospectus, at the Time of Sale, did not, and as of the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company and the Guarantors make no representation or warranty with respect to any statements or omissions
made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company and the Guarantors in writing by such Underwriter through the Representatives expressly for use
in any Issuer Free Writing Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Registration Statement and Prospectus.</I> The Registration Statement is an
&#8220;automatic shelf registration statement&#8221; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the
use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company or any Guarantor. No order suspending the effectiveness of the Registration Statement has
been issued by the Commission and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or any Guarantor or related to the offering has been initiated or threatened by the Commission; as of the
applicable effective date of the Registration Statement and any amendment thereto, the Registration Statement complied and will comply in all material respects with the Securities Act and the Trust Indenture Act of 1939, as amended, and the rules
and regulations of the Commission thereunder (collectively, the &#8220;Trust Indenture Act&#8221;), and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date, the Prospectus will not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company and the Guarantors make no
representation or warranty with respect to (i)&nbsp;that part of the Registration Statement that constitutes the Statement of Eligibility and Qualification (Form <FONT STYLE="white-space:nowrap">T-1)</FONT> of the Trustee under the Trust Indenture
Act or (ii)&nbsp;any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company and the Guarantors in writing by such Underwriter through the Representatives expressly for
use in the Registration Statement and the Prospectus and any amendment or supplement thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Incorporated Documents.</I> The
documents incorporated by reference in the Registration Statement, the Prospectus and the Time of Sale Information, when they became effective or were filed with the Commission, as the case may be, conformed in all material respects to the
requirements of the Exchange Act, and none of such documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and during the Prospectus Delivery Period (as defined in Section&nbsp;4(b)) any further documents so filed and incorporated by reference in the Registration Statement, the Prospectus or the
Time of Sale Information, when such documents become effective or are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and will not
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Financial Statements.</I> The consolidated historical financial statements and
schedules of Parent and its consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus present fairly in all material respects the financial condition, results of
operations and cash flows of Parent as of the dates and for the periods indicated, comply as to form with the applicable accounting requirements of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> and have been prepared in conformity with
generally accepted accounting principles applied on a consistent basis throughout the periods involved (except as otherwise noted therein). The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the
Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>No Material Adverse Change.</I> Since the date of the most recent financial statements of Parent included or incorporated by reference
in the Registration Statement, the Time of Sale Information and the Prospectus, (i)&nbsp;except for regular quarterly dividends payable on the ordinary shares, par value $0.0001 per share, of Parent in amounts per share that are consistent with past
practice, there has not been any material change in the capital stock or long-term debt of Parent or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by Parent on any class of capital
stock, or any material adverse change, or any development that would reasonably be expected to result in a material adverse change, in or affecting the business, properties, management, financial position or results of operations of Parent and its
subsidiaries taken as a whole; (ii)&nbsp;neither Parent nor any of its subsidiaries has entered into any transaction or agreement that is material to Parent and its subsidiaries taken as a whole or incurred any liability or obligation, direct or
contingent, that is material to Parent and its subsidiaries taken as a whole; and (iii)&nbsp;Parent and its subsidiaries, taken as a whole, have not sustained any material loss or interference with their business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except as otherwise disclosed in the Registration Statement,
the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Organization and Good Standing.</I> Parent, the Company and Medtronic Global have
each been duly organized and are validly existing as entities in good standing under the laws of Ireland, Minnesota and Luxembourg, respectively, with corporate power and authority to own their properties and conduct their business as described in
the Registration Statement, the Time of Sale Information and the Prospectus, and have been duly qualified as a foreign corporation for the transaction of business and are in good standing under the laws of each other jurisdiction in which they own
or lease properties or conduct any business so as to require such qualification, except where the failure to be so </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualified in any such jurisdiction would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the business, properties, management, financial
position or results of operations of Parent and its subsidiaries, taken as a whole (a &#8220;Material Adverse Effect&#8221;); and each of Parent&#8217;s subsidiaries that constitutes a &#8220;significant subsidiary&#8221; (as such term is defined in
Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X)</FONT> (collectively, the &#8220;Significant Subsidiaries&#8221;) has been duly organized and is validly existing in good standing under the laws
of its jurisdiction of organization except where the failure to be so organized, qualified or in good standing would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Capitalization.</I> All the outstanding shares of capital stock of each Significant Subsidiary have been duly authorized and validly
issued and are fully paid and nonassessable, and, except as otherwise set forth in the Registration Statement, the Time of Sale Information and the Prospectus, all outstanding shares of capital stock of each Significant Subsidiary are owned by
Parent either directly or through wholly-owned subsidiaries free and clear of any security interest, claim, lien or encumbrance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)
<I>Underwriting Agreement.</I> This Agreement has been duly authorized, executed and delivered by the Company and each of the Guarantors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>The Indenture. </I>The Base Indenture has been duly authorized, executed and delivered by the Company and each of the Guarantors party
thereto. The Sixth Supplemental Indenture has been duly authorized by the Company and each of the Guarantors. On the Closing Date, the Sixth Supplemental Indenture will be duly executed and delivered by the Company and each of the Guarantors and,
when duly executed and delivered in accordance with its terms by each of the other parties thereto, will constitute valid and legally binding agreements of the Company and each of the Guarantors enforceable against the Company and each of the
Guarantors in accordance with their terms, except as enforceability may be limited by applicable mandatory law provisions or bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or similar laws relating to or affecting the
enforcement of creditors&#8217; rights generally or by equitable principles relating to enforceability (collectively, the &#8220;Enforceability Exceptions&#8221;); and on the Closing Date, the Indenture will conform in all material respects to the
requirements of the Trust Indenture Act and the rules and regulations of the Commission applicable to an indenture that is qualified thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>The Agency Agreement. </I>The Agency Agreement has been duly authorized by the Company. On the Closing Date, the Agency Agreement will
be duly executed and delivered by the Company and, when duly executed and delivered in accordance with its terms by each of the other parties thereto, will constitute a valid and legally binding agreement of the Company enforceable against the
Company in accordance with its terms, except as enforceability may be limited by the Enforceability Exceptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>The Securities and the Guarantees</I>. The Securities have been duly authorized by
the Company and, when duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and outstanding and will constitute valid and legally binding obligations of the
Company enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture; and the Guarantees have been duly authorized by each of the Guarantors and, when
the Securities have been duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will constitute valid and legally binding obligations of each of the Guarantors, enforceable against each of
the Guarantors in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Descriptions of the Transaction Documents</I>. Each of this Agreement, the Securities, the Indenture (including each Guarantee set
forth therein) and the Agency Agreement (collectively, the &#8220;Transaction Documents&#8221;) conforms in all material respects to the description thereof contained in the Registration Statement, the Time of Sale Information and the Prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>No Violation or Default.</I> None of Parent, the Company or any of the Significant Subsidiaries is in violation or default of
(i)&nbsp;any provision of its certificate of incorporation, articles of association, articles of incorporation, bylaws or similar governing or organizational documents (the &#8220;Governing Documents&#8221;); (ii) the terms of any indenture,
contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which it is a party or bound or to which its property is subject; or (iii)&nbsp;any statute, law, rule,
regulation, judgment, order or decree applicable to Parent, the Company or any of the Significant Subsidiaries of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over Parent,
the Company or such Significant Subsidiary or any of its properties, as applicable, except, in the case of clauses (ii)&nbsp;and (iii), where such violation or default would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>No Conflicts. </I>None of the execution and delivery of any of the Transaction Documents by the Company and each of the Guarantors, the
issuance and sale of the Securities or the Guarantees or the consummation by the Company and the Guarantors of any other transaction contemplated by the Transaction Documents will result in a breach or violation of or imposition of any lien, charge
or encumbrance upon any property or assets of Parent, the Company or any of the Significant Subsidiaries pursuant to (i)&nbsp;the Governing Documents of Parent, the Company or any of the Significant Subsidiaries; (ii)&nbsp;the terms of any
indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which Parent or any of its subsidiaries is a party or bound or to which its or their property is
subject; or (iii)&nbsp;any statute, law, rule, regulation, judgment, order or decree of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over Parent or any of its subsidiaries or
any of its or their properties; except, in the case of clauses (ii)&nbsp;and (iii), where such violation, breach, conflict or lien would not, individually or in the aggregate, have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <I>No Consents Required</I>. No consent, approval, authorization, order, registration or
qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company and each of the Guarantors of each of the Transaction Documents, the issuance and sale of
the Securities (and the Guarantees) and compliance by the Company and each of the Guarantors with the terms thereof and the consummation of the transactions contemplated by the Transaction Documents, except for (i)&nbsp;the registration of the
Securities under the Securities Act, (ii)&nbsp;the qualification of the Indenture under the Trust Indenture Act or (iii)&nbsp;such consents, approvals, authorizations, orders and registrations or qualifications as may be required under applicable
state securities laws in connection with the purchase and distribution of the Securities by the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <I>Legal
Proceedings.</I> Except as disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving Parent,
the Company or any of the Significant Subsidiaries or its or their property is pending or, to the best knowledge of Parent, threatened that (i)&nbsp;could reasonably be expected to have a material adverse effect on the performance of any of the
Transaction Documents, or the consummation of any of the transactions contemplated hereby or thereby or (ii)&nbsp;could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <I>Independent Accountants.</I> PricewaterhouseCoopers LLP, who have audited certain financial statements of Parent and its subsidiaries,
are, to the knowledge of Parent, an independent registered public accounting firm with respect to Parent and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board
(United States) and as required by the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <I>Title to Intellectual Property.</I> Except as would not, individually or in
the aggregate, have a Material Adverse Effect, Parent, the Company and the Significant Subsidiaries own, possess, license or have other rights to use on reasonable terms, all patents, trademarks and service marks, trade names, copyrights, domain
names (in each case including all registrations and applications to register same), inventions, trade secrets, technology, <FONT STYLE="white-space:nowrap">know-how,</FONT> and other intellectual property (collectively, the &#8220;Intellectual
Property&#8221;) necessary for the conduct of Parent&#8217;s, the Company&#8217;s and the Significant Subsidiaries&#8217; respective businesses as now conducted. Except as set forth in the Registration Statement, the Time of Sale Information and the
Prospectus and except as would not, individually or in the aggregate, have a Material Adverse Effect, (i)&nbsp;Parent, the Company and the Significant Subsidiaries own, or have rights to use under license, all such Intellectual Property free and
clear of all adverse claims, liens or other encumbrances; (ii)&nbsp;to the knowledge of Parent, there is no infringement, misappropriation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or other violation by any third parties of any such Intellectual Property; (iii)&nbsp;there is no pending or, to the knowledge of Parent, threatened action, suit, proceeding or claim by any third
party challenging Parent&#8217;s, the Company&#8217;s or the Significant Subsidiaries&#8217; rights in or to any such Intellectual Property, and the Company and the Guarantors are unaware of any facts which would form a reasonable basis for any such
claim, action, suit or proceeding; (iv)&nbsp;there is no pending or, to the knowledge of Parent, threatened action, suit, proceeding or claim by any third party challenging the validity, scope or enforceability of any such Intellectual Property, and
the Company is unaware of any facts that would form a reasonable basis for any such claim, action, suit or proceeding; (v)&nbsp;there is no pending or, to the knowledge of Parent, threatened action, suit, proceeding or claim by any third party that
Parent, the Company or any Significant Subsidiary infringes, misappropriates or otherwise violates any Intellectual Property rights of any third party, and Parent is unaware of any other fact which would form a reasonable basis for any such claim,
action, suit or proceeding; and (vi)&nbsp;to the knowledge of Parent, there is no valid and subsisting patent or published patent application that would preclude Parent, the Company and the Significant Subsidiaries from practicing any Intellectual
Property necessary for the conduct of Parent&#8217;s, the Company&#8217;s and the Significant Subsidiaries&#8217; respective businesses as now conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <I>Investment Company Act.</I> Neither the Company nor any Guarantor is, and immediately after giving effect to the offering and sale of
the Securities and the application of the proceeds thereof as described in the Registration Statement, the Time of Sale Information and the Prospectus will be, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of
1940, as amended, and the rules and regulations of the Commission thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>Taxes.</I> Parent, the Company and the Significant
Subsidiaries have filed all <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> U.S. federal, state and local tax returns that are required to be filed or has requested extensions thereof (except in any case in which the failure so to file would not
have a Material Adverse Effect and except as set forth in or contemplated in the Registration Statement, the Time of Sale Information and the Prospectus) and have paid all taxes required to be paid by it and any other assessment, fine or penalty
levied against it, to the extent that any of the foregoing is due and payable, except for any such tax, assessment, fine or penalty that is currently being contested in good faith or which would not, individually or in the aggregate, have a Material
Adverse Effect and except as set forth in or contemplated in the Registration Statement, the Time of Sale Information and the Prospectus (exclusive of any amendment or supplement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <I>Compliance with Environmental Laws.</I> Parent, the Company and the Significant Subsidiaries are (i)&nbsp;in compliance with any and
all applicable <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> U.S. federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or
contaminants (&#8220;Environmental Laws&#8221;); (ii) have received and are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii)&nbsp;have
not received notice of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
actual or potential liability known to management of Parent under any Environmental Law, except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> with Environmental Laws, failure
to receive required permits, licenses or other approvals, or liability would not, individually or in the aggregate, have a Material Adverse Effect, or except as set forth in or contemplated in the Registration Statement, the Time of Sale Information
and the Prospectus (exclusive of any amendment or supplement thereto). Except as set forth in the Registration Statement, the Time of Sale Information and the Prospectus, neither Parent, the Company nor any of the Significant Subsidiaries has been
named as a &#8220;potentially responsible party&#8221; under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <I>Accounting Controls.</I> Parent, the Company and each of the Significant Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; (iv)&nbsp;the
recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v)&nbsp;the interactive data in eXtensible Business Reporting Language included or
incorporated by reference in the Registration Statement fairly presents the information called for in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)
<I>Compliance with Anti-Money Laundering Laws</I>. The operations of Parent and its subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of
the Currency and Foreign Transactions Reporting Act of 1970, as amended, the anti-money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any governmental agency (collectively, the &#8220;Anti-Money Laundering Laws&#8221;); and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving Parent or any of its
subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of Parent, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <I>Insurance</I>.
Parent, the Company and the Significant Subsidiaries self-insure against losses relating to their properties, operations, personnel and businesses, and have insurance covering their respective directors and officers which, in the Company&#8217;s and
the Guarantors&#8217; reasonable belief, is in an amount and insures against such losses and risks as are adequate to protect such directors and officers and the Parent, the Company and the Significant Subsidiaries, and such policy is in full force
and effect in all material respects, except where failure to maintain such policy would not reasonably be expected to result in a Material Adverse Effect and except as set forth in or contemplated in the Registration Statement, the Time of Sale
Information and the Prospectus (exclusive of any amendment or supplement thereto). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <I>Compliance with OFAC. </I>None of Parent, the Company or any of its Significant
Subsidiaries or, to the knowledge of Parent, any director, officer, employee or affiliate of Parent, the Company or the Significant Subsidiaries is currently the target of any U.S. sanctions administered or enforced by the Office of Foreign Assets
Control of the U.S. Department of the Treasury (&#8220;OFAC&#8221;), the U.S. Department of State, the United Nations Security Council (&#8220;UNSC&#8221;), the European Union or the United Kingdom (collectively, &#8220;Sanctions&#8221;), nor is the
Parent, Company or any of its Significant Subsidiaries located, organized or resident in a country or territory that is currently the subject of comprehensive Sanctions (currently, Crimea, the <FONT STYLE="white-space:nowrap">non-government</FONT>
controlled areas of the Zaporizhzhia and Kherson Regions of Ukraine, the <FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#8217;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#8217;s Republic and any
other Covered Region of Ukraine as may be identified by the Secretary of the Treasury, in consultation with the Secretary of State, pursuant to Executive Order 14065, Cuba, Iran, North Korea and Syria (with respect to Syria, only until July&nbsp;1,
2025)). The Company and the Guarantors will not directly or, to the knowledge of Parent, indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint
venture partner or other person or entity, for the purpose of financing the activities of any person currently the target of Sanctions or in any other manner that would result in a violation of Sanctions by any person participating in this
Agreement. The representations in this Section&nbsp;3(aa) shall not apply to, nor are they sought by or made to any person if and to the extent that it is or would be unenforceable by or in respect of that person by reason of breach of, or would
result in a violation of, or conflict with (i)&nbsp;any provision of Council Regulation (EC) No 2271/96 of 22&nbsp;November 1996, as amended (the &#8220;Blocking Regulation&#8221;) (or any law or regulation implementing such Blocking Regulation in
any member state of the European Union), and specifically with regards to Deutsche Bank AG, London Branch, Section&nbsp;7 of the German Foreign Trade Ordinance (Verordnung zur Durchf&uuml;hrung des Au&szlig;enwirtschaftsgesetzes
(Au&szlig;enwirtschaftsverordnung &#8211; AWV)) or (ii)&nbsp;the Blocking Regulation as it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (or any law or regulation implementing such
regulation in the United Kingdom). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <I>No Unlawful Payments.</I> Each of Parent and its subsidiaries and, to the knowledge of Parent,
all directors, officers or employees of Parent or any of its subsidiaries (i)&nbsp;complies and has complied in all material respects with the Bribery Act 2010 of the United Kingdom, the OECD Convention on Bribery of Foreign Public Officials in
International Business Transactions, the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder and (ii)&nbsp;with respect to Parent and its subsidiaries, have instituted and maintain and will continue to
maintain policies and procedures designed to promote and ensure continued compliance with all applicable anti-bribery and anti-corruption laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <I>No Registration Rights</I>. Except as disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, no
person has the right to require Parent or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Securities. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <I>No Stabilization.</I> Neither the Company nor any of the Guarantors has taken,
directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result, under the Exchange Act or otherwise, in stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <I>Sarbanes-Oxley Act</I>. There is and has been no failure on the part of Parent or any of Parent&#8217;s directors or officers, in
their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (the &#8220;Sarbanes-Oxley Act&#8221;), including Section&nbsp;402 related to loans and
Sections 302 and 906 related to certifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <I>Status under the Securities Act</I>. Neither the Company nor any Guarantor is an
ineligible issuer, and the Company and the Guarantors are well-known seasoned issuers, in each case as defined under the Securities Act, in each case at the times specified in the Securities Act in connection with the offering of the Securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) <I>Certain Statements</I>. The statements in the Registration Statement, the Time of Sale Information and Prospectus under
&#8220;Certain Tax Considerations&#8221; and, except for the Underwriter Information (as defined below), &#8220;Underwriting&#8221; fairly summarize the matters therein described in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <I>Stamp Taxes</I>. There are no stamp or other issuance or transfer taxes or duties or other similar fees or charges required to be paid
by or on behalf of the Underwriters in the United States, Luxembourg or Ireland or any political subdivision or taxing authority thereof in connection with the execution and delivery of the Transaction Documents or the offer or sale of the
Securities, except in the case of voluntary registration of the Transaction Documents in Luxembourg and/or the registration of the Transaction Documents in Luxembourg, which will be required where such documents are physically attached
(<I>annex&eacute;(s)</I>) to a public deed or to any other document subject to mandatory registration, in which case either a nominal registration duty or an ad valorem duty (of, for instance, 0.24 (zero point twenty four) percent of the amount of
the payment obligation mentioned in the document so registered) will be payable depending on the nature of the document to be registered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>No Withholding Tax</I>. All payments to be made by the Company or the Guarantors to the Underwriters on or by virtue of the execution
delivery, performance or enforcement of the Transaction Documents and, except as disclosed in each of the Time of Sale Information and the Prospectus, all interest, principal, premium, if any, additional amounts, if any, and other payments under the
Transaction Documents, under the current laws and regulations of the United States of America, Luxembourg or Ireland, any political subdivision thereof or any applicable taxing jurisdiction (each, a &#8220;Taxing Jurisdiction&#8221;), will not be
subject to withholding, duties, levies, deductions, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
charges or other taxes under the current laws and regulations of the Taxing Jurisdiction and are otherwise payable free and clear of any other withholding, duty, levy, deduction, charge or other
tax in the Taxing Jurisdiction and without the necessity of obtaining any governmental authorization in the Taxing Jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj)
<I>No Immunity</I>. Neither Parent nor any of its subsidiaries nor any of its or their properties or assets has any immunity from the jurisdiction of any court or from any legal process (whether through service or notice, attachment prior to
judgment, attachment in aid of execution or otherwise) under the laws of Luxembourg or Ireland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <I>Cybersecurity; Data
Protection</I>. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (i)&nbsp;the Parent&#8217;s, the Company&#8217;s and the Significant Subsidiaries&#8217; information technology, computers, systems, networks,
hardware, software and databases (collectively, &#8220;IT Systems&#8221;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Parent, the Company and the Significant
Subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants; (ii)&nbsp;the Parent, the Company and the Significant Subsidiaries have implemented and maintained
commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all
personal, personally identifiable, sensitive, confidential or regulated data (&#8220;Data&#8221;)) used in connection with their businesses; (iii)&nbsp;to the knowledge of the Parent, there has been no breach, unauthorized use or access or
compromise of any IT Systems; and (iv)&nbsp;the Parent, the Company and the Significant Subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or
arbitrator or governmental or regulatory authority, internal policies and contractual obligations applicable, in each case, to the Parent, the Company and the Significant Subsidiaries relating to the security of IT Systems and Data and to the
protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) <I>Privacy</I>. Except as
would not, individually or in the aggregate, have a Material Adverse Effect, (i)&nbsp;the Parent, the Company and the Significant Subsidiaries have complied, and are presently in compliance, in all material respects, with all applicable state,
federal and international data privacy and security laws and regulations, including without limitation, to the extent applicable, the U.S. Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) and the European Union
General Data Protection Regulation (&#8220;GDPR&#8221;) (EU 2016/679) (collectively, the &#8220;Data Security Obligations&#8221;); (ii) neither the Parent, the Company nor the Significant Subsidiaries has received any notification of or complaint
regarding, and are aware of any other facts that, individually or in the aggregate, would reasonably indicate <FONT STYLE="white-space:nowrap">non-compliance</FONT> by the Parent, the Company and the Significant Subsidiaries with any Data Security
Obligation; (iii)&nbsp;there is no pending, or to the knowledge of the Parent, threatened, action, suit or proceeding by or before any applicable court or governmental </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agency, authority or body alleging <FONT STYLE="white-space:nowrap">non-compliance</FONT> by the Parent, the Company and the Significant Subsidiaries with any Data Security Obligation;
(iv)&nbsp;to ensure compliance with the Data Security Obligations, the Parent, the Company and the Significant Subsidiaries have taken steps reasonably designed to ensure compliance in all material respects with their policies and procedures
relating to data privacy and security and the use, collection, storage, disclosure or other processing of Data that is subject to the Data Security Obligations (the &#8220;Policies&#8221;) to protect such Data against loss and unauthorized access,
use, modification, disclosure or other misuse; and (v)&nbsp;the Parent, the Company and the Significant Subsidiaries have made all disclosures of their then-current Policies to users or customers required by applicable laws and regulatory rules or
requirements, and none of such disclosures made or contained in any Policy have, to the knowledge of the Parent, been inaccurate or in violation of any applicable laws and regulatory rules or requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) <I>Submission to Jurisdiction</I>. The Company and each of the Guarantors have the power to submit, and pursuant to Section&nbsp;15(e) of
this Agreement and Section&nbsp;1.12 of the Indenture have legally, validly, effectively and irrevocably submitted, to the exclusive jurisdiction of the courts specified therein; and have the power to designate, appoint and empower, and pursuant to
Section&nbsp;15(e) of this Agreement and Section&nbsp;1.12 of the Indenture, have legally, validly and effectively designated, appointed and empowered an agent for service of process in any suit or proceeding based on or arising under this Agreement
or the Indenture, as applicable, in any court specified therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Agreements of the Company and the Guarantors</U>. The
Company and each of the Guarantors, jointly and severally, covenant and agree with each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Filings.</I> The
Company and the Guarantors will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus (including the term
sheet in the form of Annex B hereto) to the extent required by Rule 433 under the Securities Act; and will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant
to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Securities; and the Company will
furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City as soon as available on the business day next succeeding the date of this Agreement, in such
quantities as the Representatives may reasonably request. The Company will pay the registration fees for this offering within the time period required by Rule 456(b)(1)(i) under the Securities Act (without giving effect to the proviso therein) and
in any event prior to the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Delivery of Copies.</I> The Company will deliver, without charge, to each
Underwriter, including to each of the Representatives, (i)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and (ii)&nbsp;during the
Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing Prospectus as the Representatives may
reasonably request. As used herein, the term &#8220;Prospectus Delivery Period&#8221; means such period of time after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus relating to
the Securities is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Securities by any Underwriter or dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Amendments or Supplements; Issuer Free Writing Prospectuses.</I> Before making, preparing, using, authorizing, approving, referring to
or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement or the Prospectus, whether before or after the time that the Registration Statement becomes effective, the Company will furnish
to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing
Prospectus or file any such proposed amendment or supplement to which the Representatives reasonably object. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice to the
Representatives.</I> The Company will advise the Representatives promptly, and confirm such advice in writing, (i)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective; (ii)&nbsp;when any supplement to the
Prospectus or any amendment to the Prospectus or any Issuer Free Writing Prospectus has been filed; (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the
receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information; (iv)&nbsp;of the issuance by the Commission of any order suspending the effectiveness of the
Registration Statement or preventing or suspending the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (v)&nbsp;of the
occurrence of any event within the Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Time of Sale Information or any such Issuer Free Writing
Prospectus is delivered to a purchaser, not misleading; (vi)&nbsp;of the receipt by the Company or any Guarantor of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant
to Rule 401(g)(2) under the Securities Act; and (vii)&nbsp;of the receipt by the Company or any Guarantor of any notice with respect to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company and the
Guarantors will use their reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending
any such qualification of the Securities and, if any such order is issued, will obtain as soon as possible the withdrawal thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<I>Time of Sale Information.</I> If at any time prior to the Closing Date (i)&nbsp;any event shall occur or condition shall exist as a result of which the Time of Sale Information as then amended or supplemented would include any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Time of Sale
Information to comply with law, the Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to
such dealers as the Representatives may designate, such amendments or supplements to the Time of Sale Information as may be necessary so that the statements in the Time of Sale Information as so amended or supplemented will not, in the light of the
circumstances, be misleading or so that the Time of Sale Information will comply with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Ongoing Compliance</I>. If during the
Prospectus Delivery Period (i)&nbsp;any event shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus
to comply with law, the Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may
designate, such amendments or supplements to the Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a
purchaser, be misleading or so that the Prospectus will comply with law.<I> </I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Blue Sky Compliance.</I> The Company will qualify
the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for the distribution of the Securities;
<U>provided</U> that neither the Company nor any of the Guarantors shall be required to (i)&nbsp;qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so
qualify, (ii)&nbsp;file any general consent to service of process in any such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Earning Statement. </I>Parent will make generally available to its security holders
and the Representatives as soon as practicable an earning statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months beginning
with the first fiscal quarter of Parent occurring after the &#8220;effective date&#8221; (as defined in Rule 158) of the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Clear Market.</I> During the period from the date hereof through and including the Closing Date, the Company and each of the Guarantors
will not, without the prior written consent of the Representatives, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company or any of the Guarantors and having a tenor of more than one year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Use of Proceeds.</I> The Company will apply the net proceeds from the sale of the Securities as described in the Registration
Statement, the Time of Sale Information and the Prospectus under the heading &#8220;Use of Proceeds.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>No Stabilization.</I>
None of the Company or any of the Guarantors will take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Record Retention</I>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free
Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Tax Indemnity</I>.
The Company and each of the Guarantors, jointly and severally, further agree to indemnify and hold harmless the Underwriters against any documentary, stamp, registration, sales, transaction or similar issuance tax, including any interest and
penalties, on the creation, issue and sale of the Securities, and on the execution, delivery, performance and enforcement of the Transaction Documents. The Company and each of the Guarantors agree with each of the Underwriters that all payments made
to the Underwriters under the Transaction Documents shall be without withholding or deduction for or on account of any present or future taxes, duties or governmental charges whatsoever imposed by any Taxing Jurisdiction, unless the Company or any
such Guarantor, as the case may be, is compelled by law to deduct or withhold such taxes, duties or charges. In that event, the Company or such Guarantor, as the case may be, shall pay such additional amounts as may be necessary in order that the
net amounts received by each Underwriter after such withholding or deduction will equal the amounts that would have been received if no withholding or deduction has been made, except to the extent that such taxes, duties or charges (a)&nbsp;were
imposed due to some connection of an Underwriter with the Taxing Jurisdiction other than the mere entering into of this Agreement or receipt of payments hereunder or (b)&nbsp;would not have been imposed but for the failure of such Underwriter to
comply with any reasonable certification, identification or other reporting requirements concerning the nationality, residence, identity or connection with the Taxing Jurisdiction of the Underwriter if such compliance is required or imposed by law
as a precondition to an exemption from, or reduction in, such taxes, duties or other charges. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Certain Agreements of the Underwriters</U>. Each Underwriter hereby represents and
agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not used and will not use, authorize use of, refer to, or participate in the planning for use of, any &#8220;free
writing prospectus,&#8221; as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company or any Guarantor and not incorporated by reference into the Registration
Statement and any press release issued by the Company or any Guarantor) other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such underwriter, would not trigger an obligation to file such free writing prospectus with the
Commission pursuant to Rule 433, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section&nbsp;3(c) or Section&nbsp;4(c) above (including any electronic road show), or (iii)&nbsp;any free writing prospectus prepared
by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#8220;Underwriter Free Writing Prospectus&#8221;). Notwithstanding the foregoing, the Underwriters
may use a term sheet or term sheets substantially in the forms attached as Annex B hereto without the consent of the Company or any Guarantor; <U>provided</U> that any Underwriter using such term sheets shall notify the Company and provide a copy of
any such term sheet or term sheets to the Company prior to the first use of such term sheet or term sheets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It is not subject to any
pending proceeding under Section&nbsp;8A of the Securities Act with respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It will abide by the offering restrictions as set forth on Schedule II hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Conditions of Underwriters&#8217; Obligations.</U> The obligation of each Underwriter to purchase Securities on the Closing Date as
provided herein is subject to the performance by the Company and each of the Guarantors of their respective covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Registration Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be in effect, and
no proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely
filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section&nbsp;4(a) hereof; and all requests by the Commission
for additional information shall have been complied with to the reasonable satisfaction of the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Representations and Warranties.</I> The representations and warranties of the Company
and each of the Guarantors contained herein shall be true and correct on the date hereof and on and as of the Closing Date; and the statements of the Company, the Guarantors and their respective officers made in any certificates delivered pursuant
to this Agreement shall be true and correct on and as of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>No Downgrade.</I> Subsequent to the earlier of
(A)&nbsp;the Time of Sale and (B)&nbsp;the execution and delivery of this Agreement, (i)&nbsp;no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock of or guaranteed by Parent or any
of its subsidiaries by any &#8220;nationally recognized statistical rating organization,&#8221; as such term is defined by the Commission in Section&nbsp;3(a)(62) of the Exchange Act and (ii)&nbsp;no such organization shall have publicly announced
that it has under surveillance or review for possible downgrade to its rating of the Securities or of any other debt securities or preferred stock of or guaranteed by Parent or any of its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>No Material Adverse Change.</I> No event or condition of a type described in Section&nbsp;3(g) hereof shall have occurred or shall
exist, which event or condition is not described in the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the
Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Officer&#8217;s Certificate.</I> The Representatives shall have received on and as of the Closing Date a certificate of an executive
officer of Parent who has specific knowledge of Parent&#8217;s financial matters and is satisfactory to the Representatives (i)&nbsp;confirming that such officer has carefully reviewed the Registration Statement, the Time of Sale Information and the
Prospectus and, to the knowledge of such officer, the representations set forth in Sections 3(b) or 3(d) hereof are true and correct, (ii)&nbsp;confirming that the other representations and warranties of the Company and each of the Guarantors in
this Agreement are true and correct and that the Company and each of the Guarantors has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date and
(iii)&nbsp;confirming the matters set forth in paragraphs (a), (c) and (d)&nbsp;above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Comfort Letters.</I> On the date of this
Agreement and on the Closing Date, PricewaterhouseCoopers LLP shall have furnished to the Representatives, at the request of Parent, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance
reasonably satisfactory to the Representatives, containing statements and information of the type customarily included </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference in the
Registration Statement, the Time of Sale Information and the Prospectus; <U>provided</U> that the letter delivered on the Closing Date shall use a <FONT STYLE="white-space:nowrap">&#8220;cut-off&#8221;</FONT> date no more than two business days
prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Opinions and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for the Company and the
Guarantors.</I> (i)&nbsp;Wilmer Cutler Pickering Hale and Dorr LLP, counsel for the Company and the Guarantors, shall have furnished to the Representatives, at the request of the Company, their written opinion and
<FONT STYLE="white-space:nowrap">10b-5</FONT> Statement and (ii)&nbsp;Nicholas G. Benjamin, <FONT STYLE="white-space:nowrap">in-house</FONT> counsel for the Company and the Guarantors, (iii)&nbsp;A&amp;L Goodbody, special Irish counsel for Parent
and (iv)&nbsp;CM Law, special Luxembourg counsel for the Company, shall each have furnished to the Representatives, at the request of the Company, their written opinion, dated the Closing Date and addressed to the Underwriters, each in form and
substance reasonably satisfactory to the Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of
Counsel for the Underwriters.</I> The Representatives shall have received on and as of the Closing Date a written opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Davis Polk&nbsp;&amp; Wardwell LLP, counsel for the
Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Reserved.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>No
Legal Impediment to Issuance.</I> No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the
Closing Date, prevent the issuance or sale of the Securities or the issuance of the Guarantees; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale
of the Securities or the Guarantees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Good Standing</I>. The Representatives shall have received on and as of the Closing Date
satisfactory evidence of the good standing of the Company and the Guarantors, in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representatives may reasonably request, in each case in
writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Clearance
and Settlement</I>. The Securities shall be eligible for clearance and settlement through the facilities of Clearstream and Euroclear. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Supplemental Indenture. </I>The Company shall have executed and delivered the
Supplemental Indenture and the Underwriters shall have received executed copies thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Listing and Trading.</I> Application
shall have been made to list the Securities on the New York Stock Exchange for trading on the New York Stock Exchange and, in connection therewith, the Company shall have caused to be prepared and submitted to the New York Stock Exchange a listing
application with respect to the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>Additional Documents.</I> On or prior to the Closing Date, the Company and the
Guarantors shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Indemnification
and Contribution</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Indemnification of the Underwriters.</I> The Company and each of the Guarantors, jointly and severally,
agree to indemnify and hold harmless each Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act,
from and against any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are
incurred), joint or several, that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a
material fact required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Preliminary Prospectus, the
Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue
statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein (such information the
Underwriter Information, as defined below). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Indemnification of the Company and the Guarantors.</I> Each Underwriter agrees,
severally and not jointly, to indemnify and hold harmless the Company, the Guarantors, each of their respective directors, officers who signed the Registration Statement and each person, if any, who controls the Company or any of the Guarantors
within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that
arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such
Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, it being understood and agreed that
the only such information consists of the following: the second, third and fourth sentences of the third paragraph in the text under the caption &#8220;Underwriting&#8221; in the Preliminary Prospectus and the Prospectus concerning the terms of the
offering, including the concession and reallowance to certain dealers, by the Underwriters and the seventh, eighth and ninth paragraphs, and only with respect to the underwriters, of text under the caption &#8220;Underwriting&#8221; in the
Preliminary Prospectus and the Prospectus relating to over-allotment and stabilization by the Underwriters (such information, collectively, the &#8220;Underwriter Information&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Notice and Procedures.</I> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand
shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a)&nbsp;or (b) above, such person (the &#8220;Indemnified Person&#8221;) shall promptly notify the person against whom
such indemnification may be sought (the &#8220;Indemnifying Person&#8221;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under this Section&nbsp;7 except to
the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under paragraphs (a)&nbsp;or (b) of this Section&nbsp;7. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying
Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person
and any others entitled to indemnification pursuant to Section&nbsp;7 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of such proceeding and shall pay the fees and expenses of counsel related to such
proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying
Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified
Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to
actual or potential differing interest between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more
than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers
and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm for the Company, the Guarantors, each of their respective directors, officers who signed the Registration Statement and any
control persons of the Company and the Guarantors shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent
or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any
time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any
proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii)&nbsp;the Indemnifying Person shall not have reimbursed the Indemnified
Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any
Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance
reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to act by or on
behalf of any Indemnified Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Contribution.</I> If the indemnification provided for in paragraphs (a)&nbsp;and (b) above is
unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall
contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantors
on the one hand and the Underwriters on the other from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause (i)&nbsp;but also the relative fault of the Company and the Guarantors on the one hand and the Underwriters on the other in connection with the statements or omissions that resulted in such losses,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Guarantors on the one hand and the Underwriters on
the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total underwriting discounts and commissions received by the
Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Securities. The relative fault of the Company and the Guarantors on the one hand and the
Underwriters on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the
Company or any Guarantor or by the Underwriters and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Limitation on Liability.</I> The Company, the Guarantors and the Underwriters agree that it would not be just and equitable if
contribution pursuant to this Section&nbsp;7 were determined by <U>pro</U> <U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d)&nbsp;above shall be deemed to include, subject to the
limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of this Section&nbsp;7, in no event shall an Underwriter be required to
contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Securities exceeds the amount of any damages that such Underwriter has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#8217; obligations to contribute pursuant to this Section&nbsp;7 are several in proportion to their respective purchase obligations hereunder and
not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies.</I> The remedies provided for in this Section&nbsp;7
are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Effectiveness of Agreement</U>. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Termination</U>. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on the New York Stock Exchange or the Nasdaq
Stock Market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company or any of the Guarantors shall have been suspended on any exchange or in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities or European
Union authorities; or (iv)&nbsp;there shall have occurred any outbreak or escalation of hostilities or any calamity or crisis, involving the United States, Ireland or Luxembourg, or any change in the United States or international financial markets,
that, in the judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time
of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Defaulting Underwriter</U>. (a)&nbsp;If, on the Closing Date, any Underwriter defaults on
its obligation to purchase the Securities that it has agreed to purchase hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Securities by other persons
satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such
Securities, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Securities on such terms.
If other persons become obligated or agree to purchase the Securities of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date for up to five full
business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement, the Time of Sale Information and the Prospectus or in any other document or
arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement, the Time of Sale Information and the Prospectus that effects any such changes. As used in this Agreement, the term
&#8220;Underwriter&#8221; includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule I hereto that, pursuant to this Section&nbsp;10, purchases Securities that a defaulting Underwriter
agreed but failed to purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangements for the purchase of the Securities of a defaulting
Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not
exceed <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase
the principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#8217;s <U>pro</U> <U>rata</U> share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the
Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased
exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this Agreement shall terminate without
liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the Company or the Guarantors, except that
the Company and the Guarantors will continue to be liable for the payment of expenses as set forth in Section&nbsp;11 hereof and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company, the Guarantors or any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding the foregoing, for
purposes of this Section&nbsp;10, each series of Securities issued pursuant to the Indenture shall be treated as a separate series, and this Section&nbsp;10 shall apply to each series as if this Underwriting Agreement applied solely to such series.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Payment of Expenses</U><I>.</I> (a)&nbsp;Whether or not the transactions contemplated by this Agreement are consummated or this
Agreement is terminated, the Company and each of the Guarantors, jointly and severally, agree to pay or cause to be paid all costs and expenses incident to the performance of their respective obligations hereunder, including without limitation,
(i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of
the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the
costs of reproducing and distributing each of the Transaction Documents; (iv)&nbsp;the fees and expenses of the Company&#8217;s and the Guarantors&#8217; counsel and independent accountants; (v)&nbsp;the fees and expenses incurred in connection with
the registration or qualification and determination of eligibility for investment of the Securities under the laws of such jurisdictions as the Representatives may designate and the preparation, printing and distribution of a Blue Sky Memorandum
(including the reasonable related fees and expenses of counsel for the Underwriters); (vi) any fees charged by rating agencies for rating the Securities; (vii)&nbsp;the fees and expenses of the Trustee and any paying agent (including related fees
and expenses of any counsel to such parties and all fees and expenses incurred by the Company or the Guarantors in connection with the approval of the Securities for &#8220;book-entry&#8221; transfer by Clearstream and Euroclear); (viii) all
expenses and application fees incurred in connection with any filing with, and clearance of the offering by, the Financial Industry Regulatory Authority, Inc.; (ix) all fees and expenses related to the listing of the Securities on the New York Stock
Exchange; and (x)&nbsp;all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expenses incurred by the Company in connection with any &#8220;road show&#8221; presentation to potential investors. Except as provided in this Section&nbsp;11 and in Section&nbsp;7, the
Underwriters shall be responsible for paying their own expenses, on a pro rata basis in accordance with the amount of Securities purchased by such Underwriter as set forth on Schedule I, including the fees and disbursements of their counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;9, (ii) the Company for any reason fails to tender the Securities for
delivery to the Underwriters or (iii)&nbsp;the Underwriters decline to purchase the Securities for any reason permitted under this Agreement, the Company and each of the Guarantors, jointly and severally, agree to reimburse the Underwriters for all <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering
contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Underwriter agrees severally to pay the portion of the aggregate expenses of the Underwriters represented
by such Underwriter&#8217;s pro rata share (based on the proportion that the principal amount of Securities set forth opposite each Underwriter&#8217;s name in Schedule I bears to the aggregate principal amount of Securities set forth opposite the
names of all Underwriters) of the Securities (with respect to each Underwriter, the &#8220;Pro Rata Expenses&#8221;). Notwithstanding anything contained in the International Capital Markets Association Primary Market Handbook, each Underwriter
hereby agrees that the Settlement Lead Manager (as defined in Section&nbsp;15 (l)) may allocate the Pro Rata Expenses to the account of such Underwriter for settlement of accounts (including payment of such Underwriter&#8217;s fees by the Settlement
Lead Manager) as soon as practicable but in any case no later than 90 days following the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Persons Entitled to Benefit
of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each
Underwriter referred to in Section&nbsp;7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained
herein. No purchaser of Securities from any Underwriter shall be deemed to be a successor merely by reason of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.
<U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company, the Guarantors and the Underwriters contained in this Agreement or made by or on behalf of the Company, the Guarantors or
the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any
investigation made by or on behalf of the Company, the Guarantors or the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Certain Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where
otherwise expressly provided, the term &#8220;affiliate&#8221; has the meaning set forth in Rule 405 under the Securities Act; (b)&nbsp;the term &#8220;business day&#8221; means any day other than a day on which banks are permitted or required to be
closed in New York City; (c)&nbsp;the term &#8220;subsidiary&#8221; has the meaning set forth in Rule 405 under the Securities Act; and (d)&nbsp;the term &#8220;significant subsidiary&#8221; has the meaning set forth in Rule <FONT
STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act, as applied at the end of the Company&#8217;s most recently completed fiscal quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Miscellaneous</U>. (a)<I>&nbsp;Authority of the Representatives.</I> Any action by the Underwriters hereunder may be taken by the
Representatives on behalf of the Underwriters, and any such action taken by the Representatives shall be binding upon the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Patriot Act</I>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L.
<FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company and the Guarantors, which
information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Notices.</I> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed
or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to Deutsche Bank AG, London Branch, 21 Moorfields, London EC2Y 9DB, United Kingdom (telephone +44 207 545 4361), Attention: DCM Debt
Syndicate and Goldman Sachs&nbsp;&amp; Co. LLC, 200 West Street, New York, New York 10282-2198, United States, email: registration-syndops@ny.email.gs.com, Attention: Registration Department. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices to the Company and the Guarantors shall be given to Medtronic, Inc. at 710 Medtronic Parkway NE LC150, Minneapolis, Minnesota
55432-5604, Attention: Benjamin Wood, Sr. Treasury Director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Governing Law.</I> This Agreement shall be governed by and construed
in accordance with the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Consent to Jurisdiction</I>. Any legal suit, action or proceeding arising
out of or relating to this Agreement or the transactions contemplated hereby (&#8220;Related Proceedings&#8221;) shall be instituted in the federal courts of the United States of America located in the City and County of New York or the courts of
the State of New York in each case located in the City and County of New York (collectively, the &#8220;Specified Courts&#8221;), and each of the Company, the Guarantors and the other parties hereto irrevocably submits to the exclusive jurisdiction
(except for suits, actions, or proceedings instituted in regard to the enforcement of a judgment of any Specified Court in a Related Proceeding, as to which such jurisdiction is <FONT STYLE="white-space:nowrap">non-exclusive)</FONT> of the Specified
Courts in any Related Proceeding. Each of the Company and the Guarantors irrevocably </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
appoints Corporation Service Company, with offices at 80 State Street, Albany, New York 12207-2543, United States, as its agent for service of process or other legal summons for purposes of any
Related Proceeding. Service of any process, summons, notice or document by mail to such party&#8217;s address set forth in paragraph (c)&nbsp;above shall be effective service of process for any Related Proceeding brought in any Specified Court. The
Company, the Guarantors and the other parties hereto irrevocably and unconditionally waive any objection to the laying of venue of any Specified Proceeding in the Specified Courts and irrevocably and unconditionally waives and agrees not to plead or
claim in any Specified Court that any Related Proceeding brought in any Specified Court has been brought in an inconvenient forum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)
<I>Waiver of Immunity</I>. To the extent that the Company or any Guarantor has or hereafter may acquire any immunity (sovereign or otherwise) from jurisdiction of any court of (i)&nbsp;Luxembourg or Ireland or any political subdivision thereof,
(ii)&nbsp;the United States, the State of Minnesota or the State of New York, (iii)&nbsp;any jurisdiction in which they own or lease property or assets or from any legal process (whether through service of notice, attachment prior to judgment,
attachment in aid of execution, execution, <FONT STYLE="white-space:nowrap">set-off</FONT> or otherwise) with respect to themselves or their respective property and assets or this Agreement, the Company and each Guarantor hereby irrevocably waive
such immunity in respect of their obligations under this Agreement to the fullest extent permitted by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Judgment
Currency</I>. If for the purposes of obtaining judgment in any court it is necessary to convert a sum due hereunder into any currency other than United States dollars, the parties to this Agreement agree, to the fullest extent permitted by law, that
the rate of exchange used shall be the rate at which in accordance with normal banking procedures the purchasers could purchase United States dollars with such other currency in New York City on the business day preceding that on which final
judgment is given. The obligation of the Company and the Guarantors with respect to any sum due from it to any Underwriter or controlling person of such Underwriter shall, notwithstanding any judgment in a currency other than United States dollars,
not be discharged until the first business day following receipt by such Underwriter or controlling person of such Underwriter of any sum in such other currency, and only to the extent that such Underwriter or controlling person of such Underwriter
may in accordance with normal banking procedures purchase United States dollars with such other currency. If the United States dollars so purchased are less than the sum originally due to such Underwriter or controlling person of such Underwriter
hereunder, the Company and the Guarantors, jointly and severally, agree, as a separate obligation and notwithstanding any such judgment, to indemnify such Underwriter or controlling person of such Underwriter against such loss. If the United States
dollars so purchased are greater than the sum originally due to such Underwriter or controlling person of such Underwriter hereunder, such Underwriter or controlling person of such Underwriter agrees to pay to the Company or a Guarantor, as
applicable, an amount equal to the excess of the dollars so purchased over the sum originally due to such Underwriter or controlling person of such Underwriter hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Waiver of Jury Trial</I>. Each of the parties hereto hereby waives any right to trial
by jury in any suit or proceeding arising out of or relating to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Counterparts.</I> This Agreement may be signed in
counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal
ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and
validly delivered and be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Amendments or Waivers.</I> No amendment or waiver of any provision
of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Headings.</I> The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the
meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Agreement Among Underwriters</I>. The execution of this Agreement by each
Underwriter constitutes the acceptance of each Underwriter of the International Capital Markets Association Agreement Among Managers Version 1/New York Law Schedule (the &#8220;Agreement Among Managers&#8221;) as amended in the manner set out below.
For purposes of the Agreement Among Managers, &#8220;Managers&#8221; means the Underwriters, &#8220;Lead Manager&#8221; means the Representatives, &#8220;Settlement Lead Manager&#8221; means Goldman Sachs&nbsp;&amp; Co. LLC, &#8220;Stabilizing
Manager&#8221; means Goldman Sachs&nbsp;&amp; Co. LLC and &#8220;Subscription Agreement&#8221; means this Agreement. Clause 3 of the Agreement Among Managers shall be deleted in its entirety and replaced with Section&nbsp;10 of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Stabilization</I>. The Company hereby authorizes Goldman Sachs&nbsp;&amp; Co. LLC in its role as stabilizing manager (the
&#8220;Stabilizing Manager&#8221;) to make any such public disclosure as is required under applicable laws in connection with any stabilization activity undertaken by the Stabilizing Manager or any person acting on its behalf. The Stabilizing
Manager (or any person acting on behalf of the Stabilizing Manager) for its own account may, to the extent permitted by applicable laws, over-allot and effect transactions with a view to supporting the market price of the Securities at a level
higher than that which might otherwise prevail, but in doing so the Stabilizing Manager shall act as principal and not as agent of the Company and any loss resulting from overallotment and stabilization shall be borne, and any profit arising
therefrom shall be beneficially retained, by the Stabilizing Manager. However, there is no assurance that the Stabilizing Manager (or persons acting on behalf of the Stabilizing Manager) will undertake any stabilization action. Nothing contained in
this paragraph shall be construed so as to require the Company to issue in excess of the aggregate principal amount of Securities specified in Schedule I hereto. Such stabilization, if commenced, may be discontinued at any time and shall be
conducted by the Stabilizing Manager in accordance with all applicable laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) (1) <I>Contractual Recognition of European Union
<FONT STYLE="white-space:nowrap">Bail-In</FONT></I>. Notwithstanding and to the exclusion of any other term of this Agreement or any other agreements, arrangements or understandings between the Underwriters and the Company, the Company acknowledges
and accepts that a BRRD Liability (as defined below) arising under this Agreement may be subject to the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers (as defined below) by the Relevant Resolution Authority (as defined below) and
acknowledges, accepts, and agrees to be bound by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the effect of the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers
by the Relevant Resolution Authority in relation to any BRRD Liability of each Covered Underwriter (as defined below) to the Company under this Agreement, that (without limitation) may include and result in any of the following, or some combination
thereof: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(A) the reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(B) the conversion of all, or a portion, of the BRRD Liability into shares, other securities or other obligations of the relevant Covered
Underwriter or another person, and the issue to or conferral on the Company of such shares, securities or obligations; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(C) the
cancellation of the BRRD Liability; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(D) the amendment or alteration of any interest, if applicable, thereon, the maturity or the
dates on which any payments are due, including by suspending payment for a temporary period; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the variation of the terms of this
Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;15(n)(1), <FONT STYLE="white-space:nowrap">&#8220;Bail-in</FONT> Legislation&#8221; means in relation to a member
state of the European Economic Area which has implemented, or which at any time implements, the BRRD (as defined below), the relevant implementing law, regulation, rule or requirement as described in the EU
<FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule from time to time; <FONT STYLE="white-space:nowrap">&#8220;Bail-in</FONT> Powers&#8221; means any Write-down and Conversion Powers as defined in the EU <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule, in relation to the relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation; &#8220;BRRD&#8221; means Directive 2014/59/EU establishing a framework for the recovery and
resolution of credit institutions and investment firms, as amended or replaced from time to time; &#8220;BRRD Liability&#8221; means a liability in respect of which the relevant Write-Down and Conversion Powers in the applicable <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Legislation may be exercised; &#8220;Covered Underwriter&#8221; means any Underwriter subject to <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers; &#8220;EU
<FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule&#8221; means </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the document described as such, then in effect, and published by the Loan Market Association (or any successor person) from time to time at http://www.lma.eu.com/pages.aspx?p=499; and
&#8220;Relevant Resolution Authority&#8221; means the resolution authority with the ability to exercise any <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers in relation to the relevant Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) <I>Contractual Recognition of UK <FONT STYLE="white-space:nowrap">Bail-In.</FONT></I> Notwithstanding and to the exclusion of any other
term of this Agreement or any other agreements, arrangements, or understandings between the Underwriters and the Company, the Company acknowledges and accepts that a UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability (as defined below)
arising under this Agreement may be subject to the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers (as defined below) by the relevant UK resolution authority, and acknowledges, accepts, and agrees to be bound by: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the effect of the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the relevant UK resolution authority in relation
to any UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability of each Covered Underwriter (as defined below) to the Company under this Agreement, that (without limitation) may include and result in any of the following, or some combination
thereof: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(A) the reduction of all, or a portion, of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability or outstanding
amounts due thereon; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(B) the conversion of all, or a portion, of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability into
shares, other securities or other obligations of the relevant Covered Underwriter or another person, and the issue to or conferral on the Company of such shares, securities or obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(C) the cancellation of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(D) the amendment or alteration of any interest, if applicable, thereon, the maturity or the dates on which any payments are due, including
by suspending payment for a temporary period; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the variation of the terms of this Agreement, as deemed necessary by the relevant
UK resolution authority, to give effect to the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the relevant UK resolution authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;15(n)(2), &#8220;Covered Underwriter&#8221; means any Underwriter subject to UK
<FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers; &#8220;UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation&#8221; means Part I of the UK Banking Act 2009 and any other law or regulation applicable in the United Kingdom relating to
the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (otherwise than through liquidation, administration or other insolvency proceedings); &#8220;UK
<FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability&#8221; means a liability in respect of which the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers may be exercised; and &#8220;UK <FONT STYLE="white-space:nowrap">Bail-in</FONT>
Powers&#8221; means the powers under the UK <FONT STYLE="white-space:nowrap">Bail-In</FONT> Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or affiliate of a bank or investment firm, to cancel,
reduce, modify or change the form of a liability of such a person or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to
provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>MiFID II Product Governance Rules</I>. Solely for the purposes of the requirements of
Article 9(8) of the MiFID II Product Governance rules under EU Delegated Directive 2017/593 (the &#8220;EU MiFID Product Governance Rules&#8221;) regarding the mutual responsibilities of manufacturers under the EU MiFID Product Governance Rules:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Deutsche Bank AG, London Branch (an &#8220;EU Manufacturer&#8221;) acknowledges that it understands the responsibilities conferred
upon it under the EU MiFID Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Securities and the related information set out in the Prospectus in
connection with the Securities; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Company and the Underwriters (other than the EU Manufacturer) note the application of the EU
MiFID Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Securities by the EU Manufacturer and the related information set out in the Prospectus in connection with the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>UK MiFIR Product Governance Rules</I>. Solely for the purposes of the requirements of 3.2.7R of the FCA Handbook Product Intervention
and Product Governance Sourcebook (the &#8220;UK MiFIR Product Governance Rules&#8221;) regarding the mutual responsibilities of manufacturers under the UK MiFIR Product Governance Rules: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) each of Deutsche Bank AG, London Branch and Goldman Sachs&nbsp;&amp; Co. LLC (each a &#8220;UK Manufacturer&#8221; and together the
&#8220;UK Manufacturers&#8221;) acknowledges to each other UK Manufacturer that it understands the responsibilities conferred upon it under the UK MiFIR Product Governance Rules relating to each of the product approval process, the target market and
the proposed distribution channels as applying to the Securities and the related information set out in the Prospectus in connection with the Securities; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Company and the Underwriters (other than the UK Manufacturers) note the application of the UK MiFIR Product Governance Rules and
acknowledge the target market and the proposed distribution channels as applying to the Securities and the related information set out in the Prospectus in connection with the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <I>Recognition of the U.S. Special Resolution Regimes</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S. Special
Resolution Regime (as defined below), the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special
Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Underwriter becomes subject
to a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be
exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;15(q), &#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall
be interpreted in accordance with, 12 U.S.C. &#167; 1841(k); &#8220;Covered Entity&#8221; means any of the following (A)&nbsp;a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);
(B) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (C)&nbsp;a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b); &#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and &#8220;U.S. Special Resolution Regime&#8221; means each of
(x)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (y)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Pages Follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MEDTRONIC, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sheila Quintus</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Sheila Quintus</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President&nbsp;&amp; Treasurer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MEDTRONIC PUBLIC LIMITED COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sheila Quintus</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Sheila Quintus</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President&nbsp;&amp; Treasurer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MEDTRONIC GLOBAL HOLDINGS S.C.A.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Luxembourg corporate partnership limited by shares (soci&eacute;t&eacute; en commandite par actions) represented by Medtronic GP S.&agrave; r.l. its general partner, in turn acting by</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Salvador Sens</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Salvador Sens</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: September&nbsp;15, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deutsche Bank AG, London Branch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co.
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Limited </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Academy Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independence Point Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Samuel A. Ramirez&nbsp;&amp; Company, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Siebert Williams
Shank&nbsp;&amp; Co., LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Deutsche Bank AG, London Branch</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ryan E. Montgomery</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Ryan E. Montgomery</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin Prior</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Kevin Prior</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Karim Saleh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Karim Saleh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Bank Name: Barclays Bank PLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mirrette Grant</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Mirrette Grant</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorised Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Bank Name: Citigroup Global Markets Limited</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Paula Clarke</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Paula Clarke</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Delegated Signatory</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Bank Name: Academy Securities, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Boyd</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Michael Boyd</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Compliance Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Bank Name: Independence Point Securities LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Meghan Siripurapu</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Meghan Siripurapu</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Partner</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Bank Name: Samuel A. Ramirez&nbsp;&amp; Company, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lawrence F. Goldman</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Lawrence F. Goldman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Bank Name: Siebert Williams Shank&nbsp;&amp; Co., LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Finkelstein</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Finkelstein, CFA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Sr. Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Medtronic, Inc. Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Schedule I </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate Principal Amount of<BR>Securities to be Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2030 Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2045 Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deutsche Bank AG, London Branch</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Limited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Academy Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Independence Point Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Samuel A. Ramirez&nbsp;&amp; Company, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Siebert Williams Shank&nbsp;&amp; Co., LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">750,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">750,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Schedule II </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Offering Restrictions </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European
Economic Area </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes may not be offered, sold or otherwise made available to and should not be offered, sold or otherwise made
available to any retail investor in the EEA. For the purposes of this provision: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the expression &#8220;retail investor&#8221; means a person who is one
(or more) of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a retail client as defined in point (11)&nbsp;of Article 4(1) of MiFID II; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a customer within the meaning of Directive 2016/97/EU (as amended or superseded, &#8220;IMD&#8221;), where that
customer would not qualify as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>United Kingdom
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes may not be offered, sold or otherwise made available and should not be offered, sold or otherwise made available to any
retail investor in the United Kingdom. For the purposes of this provision, the expression &#8220;retail investor&#8221; means a person who is one (or more) of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a retail client, as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No 2017/565 as it forms part of
domestic law by virtue of the EUWA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to
implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the FSMA) in
connection with the issue or sale of the notes may only be communicated or caused to be communicated in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to Medtronic, Inc., Medtronic plc or Medtronic Luxco. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All applicable provisions of the FSMA must be complied with in respect to anything done by any person in relation to the notes in, from or
otherwise involving the United Kingdom. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as
defined in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument
<FONT STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the notes must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus
requirements of applicable securities laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces oexr territories of Canada may provide a
purchaser with remedies for rescission or damages if the prospectus supplement and the accompanying prospectus (including any amendment thereto) contain a misrepresentation, provided that the remedies for rescission or damages are exercised by the
purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or
territory for particulars of these rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument <FONT
STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriters are not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT>
regarding underwriter conflicts of interest in connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes may not be offered or sold in Hong Kong, by means of any document other than (i)&nbsp;to &#8220;professional investors&#8221; as
defined in the Securities and Futures Ordinance (Cap.571 of the Laws of Hong Kong) (the &#8220;SFO&#8221;) and any rules made under the SFO, or (ii)&nbsp;in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as
defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.32 of the Laws of Hong Kong) (the &#8220;C(WUMP)O&#8221;) or which do not constitute an offer to the public within the meaning of the C(WUMP)O. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No advertisement, invitation or document relating to the notes may be issued, or has been or may be in the possession of any person for the purposes of issue
(in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with
respect to notes which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the SFO and any rules made under the SFO. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes offered by this
prospectus supplement and the accompanying prospectus have not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No.&nbsp;25 of 1948, as amended (the &#8220;FIEA&#8221;)). The notes offered by this
prospectus supplement and the accompanying prospectus have not been directly or indirectly offered or sold, and will not be directly or indirectly offered or sold in Japan or to, or for the benefit of, any resident of Japan (as defined under Item 5,
Paragraph 1, Article 6 of the Foreign Exchange and Foreign Trade Act (Act No.&nbsp;228 of 1949, as amended)), or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to, or for the benefit
of, a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the FIEA and any other applicable laws, regulations and ministerial guidelines of Japan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus have not been and will not be registered as a prospectus with the Monetary Authority
of Singapore. Accordingly, this prospectus supplement, the accompanying prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the notes, may not be circulated or
distributed, nor may the notes be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor (as defined in
Section&nbsp;4A of the Securities and Futures Act 2001 of Singapore, as modified or amended from time to time (the &#8220;SFA&#8221;)) pursuant to Section&nbsp;274 of the SFA or (ii)&nbsp;to an accredited investor (as defined in Section&nbsp;4A of
the SFA) pursuant to and in accordance with the conditions specified in Section&nbsp;275 of the SFA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ireland </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any issuance or placement of the notes must be in conformity with: (a)&nbsp;the European Union (Markets in Financial Instruments) Regulations
2017 (S.I. 375 of 2017) and Regulation (EU) No.&nbsp;600 of 2014, and any codes of conduct used in connection therewith and the provisions of the Investor Compensation Act 1998 (to the extent applicable); (b) the provisions of the Companies Act 2014
(as amended), the Irish Central Bank Acts 1942 to 2018 (as amended) and any codes of conduct rules made under Section&nbsp;117(1) of the Central Bank Act 1989; (c) the provisions of the European Union (Prospectus) Regulations 2019 (S.I. 380 of 2019)
(as amended) and any rules issued under Section&nbsp;1363 of the Companies Act 2014 (as amended) by the Central Bank of Ireland; and (d)&nbsp;the provisions of the Market Abuse Regulation (EU 596/2014), the European Union (Market Abuse) Regulations
2016 (S.I. 349 of 2016) and any rules issued under Section&nbsp;1370 of the Companies Act 2014 (as amended) by the Central Bank of Ireland. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Annex A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Time of Sale Information </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Prospectus Supplement dated September 15, 2025 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pricing Term Sheet dated September 15, 2025 in the form set forth on Annex B </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Annex B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Pricing Term Sheet </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(as follows)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Medtronic, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pricing Term Sheet </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>September&nbsp;15, 2025 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Medtronic, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Guarantors:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Medtronic plc and Medtronic Global Holdings S.C.A.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trade Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">September&nbsp;15, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Settlement Date*:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">T+10; September&nbsp;29, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Denominations:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">&#128;100,000 x &#128;1,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Listing:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Issuer intends to apply to list the securities offered hereby on the New York Stock Exchange</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joint Bookrunners:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deutsche Bank AG, London Branch</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Senior <FONT STYLE="white-space:nowrap">Co-Managers:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Citigroup Global
Markets Limited</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Academy Securities, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independence Point Securities LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Samuel A. Ramirez&nbsp;&amp;
Company, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Siebert Williams Shank&nbsp;&amp; Co., LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Principal Amount:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#128;750,000,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#128;750,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.950% Senior Notes due 2030</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.200% Senior Notes due 2045</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Security Type/Format:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Notes/SEC Registered</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Notes/SEC Registered</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maturity Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">October&nbsp;15, 2030</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">October&nbsp;15, 2045</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Coupon:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.950%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.200%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Price to Public:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.974%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.897%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yield to Maturity:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.956%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.208%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Reference to <FONT STYLE="white-space:nowrap">Mid-Swaps</FONT> Rate (Interpolated):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.356%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.908%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Spread to <FONT STYLE="white-space:nowrap">Mid-Swaps:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">60 bps</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">130 bps</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Spread to Benchmark Bund:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">71.6 bps</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">105.8 bps</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Bund:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DBR 0.000% due August&nbsp;15, 2030</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DBR 2.500% due July&nbsp;4, 2044</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Bund Price and Yield:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">89.695% / 2.240%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">90.880% / 3.150%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Payment Dates:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Annually on October&nbsp;15 of each year, beginning on October&nbsp;15, 2025</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Annually on October&nbsp;15 of each year, beginning on October&nbsp;15, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Day Count Convention:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Actual/Actual (ICMA)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Actual/Actual (ICMA)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Optional Redemption:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Issuer may redeem the 2030 Notes in whole or in part, at any time prior to September&nbsp;15, 2030 (one month prior to their maturity date) at a redemption price equal to the greater of:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Issuer may redeem the 2045 Notes in whole or in part, at any time prior to April&nbsp;15, 2045 (six months prior to their maturity date) at a redemption price equal to the greater of:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) 100% of the principal amount of the 2030 Notes being redeemed; and</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) the sum of the present values of the remaining scheduled payments of principal and
interest on the 2030 Notes to be redeemed (excluding any portion of such payments of interest accrued and paid as of the date of redemption and assuming that the 2030 Notes matured on September&nbsp;15, 2030), discounted to the redemption date on an
annual basis at the Comparable Bond Rate, as described in the preliminary prospectus supplement, plus 15 basis points, plus, in each case, accrued and unpaid interest to, but not including, the date of redemption.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In addition, at any time on or after September&nbsp;15, 2030 (one month prior to their
maturity date), the Issuer may at its option redeem the 2030 Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 2030 Notes being redeemed, plus accrued and unpaid interest, if any, to, but not including,
the date of redemption.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) 100% of the principal amount of the 2045 Notes being redeemed; and</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) the sum of the present values of the remaining scheduled payments of principal and
interest on the 2045 Notes to be redeemed (excluding any portion of such payments of interest accrued and paid as of the date of redemption and assuming that the 2045 Notes matured on April&nbsp;15, 2045), discounted to the redemption date on an
annual basis at the Comparable Bond Rate, as described in the preliminary prospectus supplement, plus 20 basis points, plus, in each case, accrued and unpaid interest to, but not including, the date of redemption.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In addition, at any time on or after April&nbsp;15, 2045 (six months prior to their
maturity date), the Issuer may at its option redeem the 2045 Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 2045 Notes being redeemed, plus accrued and unpaid interest, if any, to, but not including,
the date of redemption.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CUSIP:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">585055 BZ8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">585055 CA2</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ISIN:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XS3185369371</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XS3185369454</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Common Code:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">318536937</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">318536945</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>*</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>The Issuer expects to deliver the securities offered hereby against payment for such securities on
September&nbsp;29, 2025, the tenth business day following the date of this pricing term sheet (&#8220;T+10&#8221;). Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> of the Exchange Act, trades in the secondary market generally are required
to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the securities prior to the first business day preceding the settlement date will be required, by virtue of the fact
that the securities initially settle in T+10, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement.</B> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to
which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer and the guarantors have filed with the SEC for more complete information about the Issuer and the
guarantors and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Issuer, any Guarantor, any underwriter or any dealer participating in the offering will arrange to send you
the prospectus if you request it by contacting Deutsche Bank AG, London Branch toll-free at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-800-503-4611</FONT></FONT></FONT> or Goldman
Sachs&nbsp;&amp; Co. LLC toll-free at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-866-471-2526.</FONT></FONT></FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This pricing term sheet supplements the preliminary form of prospectus supplement filed by Medtronic, Inc. on September&nbsp;15, 2025 relating to its
prospectus dated March&nbsp;3, 2023. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Relevant stabilization regulations including FCA/ICMA apply. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>UK MiFIR and MiFID II professionals/ECPs-only / No UK or EEA PRIIPs KID &#8211; Manufacturer target market (UK MiFIR product governance) is eligible
counterparties and professional clients only (all distribution channels). No EEA or UK PRIIPs key information document (KID) has been prepared as the securities offered hereby are not available to retail investors in the EEA or the UK. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was
automatically generated as a result of this communication being sent by Bloomberg or another email system. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mdt-20250915.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 9/15/2025 6:40:50 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:mdt="http://www.medtronic.com/20250915"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:us-types="http://fasb.org/us-types/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.medtronic.com/20250915"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" namespace="http://fasb.org/us-types/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20250915_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20250915_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20250915_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="mdt_A0.000SeniorNotesDue2025Member" name="A0.000SeniorNotesDue2025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A2.625SeniorNotesDue2025Member" name="A2.625SeniorNotesDue2025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A1.125SeniorNotesDue2027Member" name="A1.125SeniorNotesDue2027Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A0.375SeniorNotesDue2028Member" name="A0.375SeniorNotesDue2028Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A3.000SeniorNotesDue2028Member" name="A3.000SeniorNotesDue2028Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A3.650SeniorNotesDue2029Member" name="A3.650SeniorNotesDue2029Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A1.625SeniorNotesDue2031Member" name="A1.625SeniorNotesDue2031Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A1.000SeniorNotesDue2031Member" name="A1.000SeniorNotesDue2031Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A3.125SeniorNotesDue2031Member" name="A3.125SeniorNotesDue2031Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A0.750SeniorNotesDue2032Member" name="A0.750SeniorNotesDue2032Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A3.375SeniorNotesDue2034Member" name="A3.375SeniorNotesDue2034Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A3.875SeniorNotesDue2036Member" name="A3.875SeniorNotesDue2036Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A2.250SeniorNotesDue2039Member" name="A2.250SeniorNotesDue2039Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A1.500SeniorNotesDue2039Member" name="A1.500SeniorNotesDue2039Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A1.375SeniorNotesDue2040Member" name="A1.375SeniorNotesDue2040Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A4.150SeniorNotesDue2043Member" name="A4.150SeniorNotesDue2043Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A1.750SeniorNotesDue2049Member" name="A1.750SeniorNotesDue2049Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A1.625SeniorNotesDue2050Member" name="A1.625SeniorNotesDue2050Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mdt_A4.150SeniorNotesDue2053Member" name="A4.150SeniorNotesDue2053Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mdt-20250915_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 9/15/2025 6:40:53 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="mdt-20250915.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.000SeniorNotesDue2025Member" xlink:type="locator" xlink:label="mdt_A0.000SeniorNotesDue2025Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A2.625SeniorNotesDue2025Member" xlink:type="locator" xlink:label="mdt_A2.625SeniorNotesDue2025Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.125SeniorNotesDue2027Member" xlink:type="locator" xlink:label="mdt_A1.125SeniorNotesDue2027Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.375SeniorNotesDue2028Member" xlink:type="locator" xlink:label="mdt_A0.375SeniorNotesDue2028Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.000SeniorNotesDue2028Member" xlink:type="locator" xlink:label="mdt_A3.000SeniorNotesDue2028Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.650SeniorNotesDue2029Member" xlink:type="locator" xlink:label="mdt_A3.650SeniorNotesDue2029Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.625SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A1.625SeniorNotesDue2031Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.000SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A1.000SeniorNotesDue2031Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.125SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A3.125SeniorNotesDue2031Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.750SeniorNotesDue2032Member" xlink:type="locator" xlink:label="mdt_A0.750SeniorNotesDue2032Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.375SeniorNotesDue2034Member" xlink:type="locator" xlink:label="mdt_A3.375SeniorNotesDue2034Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.875SeniorNotesDue2036Member" xlink:type="locator" xlink:label="mdt_A3.875SeniorNotesDue2036Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A2.250SeniorNotesDue2039Member" xlink:type="locator" xlink:label="mdt_A2.250SeniorNotesDue2039Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.500SeniorNotesDue2039Member" xlink:type="locator" xlink:label="mdt_A1.500SeniorNotesDue2039Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.375SeniorNotesDue2040Member" xlink:type="locator" xlink:label="mdt_A1.375SeniorNotesDue2040Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A4.150SeniorNotesDue2043Member" xlink:type="locator" xlink:label="mdt_A4.150SeniorNotesDue2043Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.750SeniorNotesDue2049Member" xlink:type="locator" xlink:label="mdt_A1.750SeniorNotesDue2049Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.625SeniorNotesDue2050Member" xlink:type="locator" xlink:label="mdt_A1.625SeniorNotesDue2050Member" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A4.150SeniorNotesDue2053Member" xlink:type="locator" xlink:label="mdt_A4.150SeniorNotesDue2053Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntitiesTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0.01" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="18" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A0.000SeniorNotesDue2025Member" order="19" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A2.625SeniorNotesDue2025Member" order="20" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.125SeniorNotesDue2027Member" order="21" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A0.375SeniorNotesDue2028Member" order="22" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.000SeniorNotesDue2028Member" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.650SeniorNotesDue2029Member" order="24" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.625SeniorNotesDue2031Member" order="25" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.000SeniorNotesDue2031Member" order="26" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.125SeniorNotesDue2031Member" order="27" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A0.750SeniorNotesDue2032Member" order="28" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.375SeniorNotesDue2034Member" order="29" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.875SeniorNotesDue2036Member" order="30" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A2.250SeniorNotesDue2039Member" order="31" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.500SeniorNotesDue2039Member" order="32" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.375SeniorNotesDue2040Member" order="33" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A4.150SeniorNotesDue2043Member" order="34" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.750SeniorNotesDue2049Member" order="35" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.625SeniorNotesDue2050Member" order="36" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A4.150SeniorNotesDue2053Member" order="37" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCountry" order="26.061" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CountryRegion" order="30.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CityAreaCode" order="30.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30.021" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_Security12bTitle" order="39.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_TradingSymbol" order="40.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="41.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="42.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="44.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.071" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="46.001" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mdt-20250915_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 9/15/2025 6:40:50 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitiesTable" xlink:to="dei_EntitiesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entities [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ordinary shares, par value $0.0001 per share [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.000SeniorNotesDue2025Member" xlink:type="locator" xlink:label="mdt_A0.000SeniorNotesDue2025Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A0.000SeniorNotesDue2025Member" xlink:to="mdt_A0.000SeniorNotesDue2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A0.000SeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">0.000% Senior Notes due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A0.000SeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">0.000% Senior Notes due 2025 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A2.625SeniorNotesDue2025Member" xlink:type="locator" xlink:label="mdt_A2.625SeniorNotesDue2025Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A2.625SeniorNotesDue2025Member" xlink:to="mdt_A2.625SeniorNotesDue2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A2.625SeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">2.625% Senior Notes due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A2.625SeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2.625% Senior Notes due 2025 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.125SeniorNotesDue2027Member" xlink:type="locator" xlink:label="mdt_A1.125SeniorNotesDue2027Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A1.125SeniorNotesDue2027Member" xlink:to="mdt_A1.125SeniorNotesDue2027Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A1.125SeniorNotesDue2027Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.125% Senior Notes due 2027 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A1.125SeniorNotesDue2027Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.125% Senior Notes due 2027 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.375SeniorNotesDue2028Member" xlink:type="locator" xlink:label="mdt_A0.375SeniorNotesDue2028Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A0.375SeniorNotesDue2028Member" xlink:to="mdt_A0.375SeniorNotesDue2028Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A0.375SeniorNotesDue2028Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">0.375% Senior Notes due 2028 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A0.375SeniorNotesDue2028Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">0.375% Senior Notes due 2028 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.000SeniorNotesDue2028Member" xlink:type="locator" xlink:label="mdt_A3.000SeniorNotesDue2028Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A3.000SeniorNotesDue2028Member" xlink:to="mdt_A3.000SeniorNotesDue2028Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A3.000SeniorNotesDue2028Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">3.000% Senior Notes due 2028 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A3.000SeniorNotesDue2028Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">3.000% Senior Notes due 2028 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.650SeniorNotesDue2029Member" xlink:type="locator" xlink:label="mdt_A3.650SeniorNotesDue2029Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A3.650SeniorNotesDue2029Member" xlink:to="mdt_A3.650SeniorNotesDue2029Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A3.650SeniorNotesDue2029Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">3.650% Senior Notes due 2029 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A3.650SeniorNotesDue2029Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">3.650% Senior Notes due 2029 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.625SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A1.625SeniorNotesDue2031Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A1.625SeniorNotesDue2031Member" xlink:to="mdt_A1.625SeniorNotesDue2031Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A1.625SeniorNotesDue2031Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.625% Senior Notes due 2031 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A1.625SeniorNotesDue2031Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.625% Senior Notes due 2031 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.000SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A1.000SeniorNotesDue2031Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A1.000SeniorNotesDue2031Member" xlink:to="mdt_A1.000SeniorNotesDue2031Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A1.000SeniorNotesDue2031Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.000% Senior Notes due 2031 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A1.000SeniorNotesDue2031Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.000% Senior Notes due 2031 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.125SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A3.125SeniorNotesDue2031Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A3.125SeniorNotesDue2031Member" xlink:to="mdt_A3.125SeniorNotesDue2031Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A3.125SeniorNotesDue2031Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">3.125% Senior Notes due 2031 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A3.125SeniorNotesDue2031Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">3.125% Senior Notes due 2031 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.750SeniorNotesDue2032Member" xlink:type="locator" xlink:label="mdt_A0.750SeniorNotesDue2032Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A0.750SeniorNotesDue2032Member" xlink:to="mdt_A0.750SeniorNotesDue2032Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A0.750SeniorNotesDue2032Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">0.750% Senior Notes due 2032 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A0.750SeniorNotesDue2032Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">0.750% Senior Notes due 2032 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.375SeniorNotesDue2034Member" xlink:type="locator" xlink:label="mdt_A3.375SeniorNotesDue2034Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A3.375SeniorNotesDue2034Member" xlink:to="mdt_A3.375SeniorNotesDue2034Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A3.375SeniorNotesDue2034Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">3.375% Senior Notes due 2034 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A3.375SeniorNotesDue2034Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">3.375% Senior Notes due 2034 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.875SeniorNotesDue2036Member" xlink:type="locator" xlink:label="mdt_A3.875SeniorNotesDue2036Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A3.875SeniorNotesDue2036Member" xlink:to="mdt_A3.875SeniorNotesDue2036Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A3.875SeniorNotesDue2036Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">3.875% Senior Notes due 2036 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A3.875SeniorNotesDue2036Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">3.875% Senior Notes due 2036 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A2.250SeniorNotesDue2039Member" xlink:type="locator" xlink:label="mdt_A2.250SeniorNotesDue2039Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A2.250SeniorNotesDue2039Member" xlink:to="mdt_A2.250SeniorNotesDue2039Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A2.250SeniorNotesDue2039Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">2.250% Senior Notes due 2039 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A2.250SeniorNotesDue2039Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2.250% Senior Notes due 2039 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.500SeniorNotesDue2039Member" xlink:type="locator" xlink:label="mdt_A1.500SeniorNotesDue2039Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A1.500SeniorNotesDue2039Member" xlink:to="mdt_A1.500SeniorNotesDue2039Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A1.500SeniorNotesDue2039Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.500% Senior Notes due 2039 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A1.500SeniorNotesDue2039Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.500% Senior Notes due 2039 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.375SeniorNotesDue2040Member" xlink:type="locator" xlink:label="mdt_A1.375SeniorNotesDue2040Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A1.375SeniorNotesDue2040Member" xlink:to="mdt_A1.375SeniorNotesDue2040Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A1.375SeniorNotesDue2040Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.375% Senior Notes due 2040 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A1.375SeniorNotesDue2040Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.375% Senior Notes due 2040 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A4.150SeniorNotesDue2043Member" xlink:type="locator" xlink:label="mdt_A4.150SeniorNotesDue2043Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A4.150SeniorNotesDue2043Member" xlink:to="mdt_A4.150SeniorNotesDue2043Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A4.150SeniorNotesDue2043Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">4.150% Senior Notes due 2043 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A4.150SeniorNotesDue2043Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">4.150% Senior Notes due 2043 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.750SeniorNotesDue2049Member" xlink:type="locator" xlink:label="mdt_A1.750SeniorNotesDue2049Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A1.750SeniorNotesDue2049Member" xlink:to="mdt_A1.750SeniorNotesDue2049Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A1.750SeniorNotesDue2049Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.750% Senior Notes due 2049 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A1.750SeniorNotesDue2049Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.750% Senior Notes due 2049 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.625SeniorNotesDue2050Member" xlink:type="locator" xlink:label="mdt_A1.625SeniorNotesDue2050Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A1.625SeniorNotesDue2050Member" xlink:to="mdt_A1.625SeniorNotesDue2050Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A1.625SeniorNotesDue2050Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.625% Senior Notes due 2050 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A1.625SeniorNotesDue2050Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.625% Senior Notes due 2050 [Member]</link:label>
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A4.150SeniorNotesDue2053Member" xlink:type="locator" xlink:label="mdt_A4.150SeniorNotesDue2053Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdt_A4.150SeniorNotesDue2053Member" xlink:to="mdt_A4.150SeniorNotesDue2053Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="mdt_A4.150SeniorNotesDue2053Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">4.150% Senior Notes due 2053 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mdt_A4.150SeniorNotesDue2053Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">4.150% Senior Notes due 2053 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 2</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Country Region</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Country Region</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mdt-20250915_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 9/15/2025 6:40:50 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="mdt-20250915.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitiesTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="dei_EntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0.01" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.000SeniorNotesDue2025Member" xlink:type="locator" xlink:label="mdt_A0.000SeniorNotesDue2025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A0.000SeniorNotesDue2025Member" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A2.625SeniorNotesDue2025Member" xlink:type="locator" xlink:label="mdt_A2.625SeniorNotesDue2025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A2.625SeniorNotesDue2025Member" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.125SeniorNotesDue2027Member" xlink:type="locator" xlink:label="mdt_A1.125SeniorNotesDue2027Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.125SeniorNotesDue2027Member" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.375SeniorNotesDue2028Member" xlink:type="locator" xlink:label="mdt_A0.375SeniorNotesDue2028Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A0.375SeniorNotesDue2028Member" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.000SeniorNotesDue2028Member" xlink:type="locator" xlink:label="mdt_A3.000SeniorNotesDue2028Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.000SeniorNotesDue2028Member" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.650SeniorNotesDue2029Member" xlink:type="locator" xlink:label="mdt_A3.650SeniorNotesDue2029Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.650SeniorNotesDue2029Member" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.625SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A1.625SeniorNotesDue2031Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.625SeniorNotesDue2031Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.000SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A1.000SeniorNotesDue2031Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.000SeniorNotesDue2031Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.125SeniorNotesDue2031Member" xlink:type="locator" xlink:label="mdt_A3.125SeniorNotesDue2031Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.125SeniorNotesDue2031Member" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A0.750SeniorNotesDue2032Member" xlink:type="locator" xlink:label="mdt_A0.750SeniorNotesDue2032Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A0.750SeniorNotesDue2032Member" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.375SeniorNotesDue2034Member" xlink:type="locator" xlink:label="mdt_A3.375SeniorNotesDue2034Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.375SeniorNotesDue2034Member" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A3.875SeniorNotesDue2036Member" xlink:type="locator" xlink:label="mdt_A3.875SeniorNotesDue2036Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A3.875SeniorNotesDue2036Member" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A2.250SeniorNotesDue2039Member" xlink:type="locator" xlink:label="mdt_A2.250SeniorNotesDue2039Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A2.250SeniorNotesDue2039Member" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.500SeniorNotesDue2039Member" xlink:type="locator" xlink:label="mdt_A1.500SeniorNotesDue2039Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.500SeniorNotesDue2039Member" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.375SeniorNotesDue2040Member" xlink:type="locator" xlink:label="mdt_A1.375SeniorNotesDue2040Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.375SeniorNotesDue2040Member" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A4.150SeniorNotesDue2043Member" xlink:type="locator" xlink:label="mdt_A4.150SeniorNotesDue2043Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A4.150SeniorNotesDue2043Member" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.750SeniorNotesDue2049Member" xlink:type="locator" xlink:label="mdt_A1.750SeniorNotesDue2049Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.750SeniorNotesDue2049Member" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A1.625SeniorNotesDue2050Member" xlink:type="locator" xlink:label="mdt_A1.625SeniorNotesDue2050Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A1.625SeniorNotesDue2050Member" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="mdt-20250915.xsd#mdt_A4.150SeniorNotesDue2053Member" xlink:type="locator" xlink:label="mdt_A4.150SeniorNotesDue2053Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mdt_A4.150SeniorNotesDue2053Member" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCountry" order="26.061" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CountryRegion" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CityAreaCode" order="30.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_Security12bTitle" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_TradingSymbol" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.071" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 15,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medtronic plc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1183488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">Building Two<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Parkmore Business Park West<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Galway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">H91 VY19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">438-1700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001613103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares, par value $0.0001 per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Ordinary shares, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A0.000SeniorNotesDue2025Member', window );">0.000% Senior Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">0.000% Senior Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A2.625SeniorNotesDue2025Member', window );">2.625% Senior Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.625% Senior Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A1.125SeniorNotesDue2027Member', window );">1.125% Senior Notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.125% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A0.375SeniorNotesDue2028Member', window );">0.375% Senior Notes due 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">0.375% Senior Notes due 2028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A3.000SeniorNotesDue2028Member', window );">3.000% Senior Notes due 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.000% Senior Notes due 2028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/28A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A3.650SeniorNotesDue2029Member', window );">3.650% Senior Notes due 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.650% Senior Notes due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A1.625SeniorNotesDue2031Member', window );">1.625% Senior Notes due 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.625% Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A1.000SeniorNotesDue2031Member', window );">1.000% Senior Notes due 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.000% Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A3.125SeniorNotesDue2031Member', window );">3.125% Senior Notes due 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.125% Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A0.750SeniorNotesDue2032Member', window );">0.750% Senior Notes due 2032 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">0.750% Senior Notes due 2032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A3.375SeniorNotesDue2034Member', window );">3.375% Senior Notes due 2034 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.375% Senior Notes due 2034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A3.875SeniorNotesDue2036Member', window );">3.875% Senior Notes due 2036 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.875% Senior Notes due 2036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A2.250SeniorNotesDue2039Member', window );">2.250% Senior Notes due 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.250% Senior Notes due 2039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A1.500SeniorNotesDue2039Member', window );">1.500% Senior Notes due 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.500% Senior Notes due 2039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A1.375SeniorNotesDue2040Member', window );">1.375% Senior Notes due 2040 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.375% Senior Notes due 2040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/40A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A4.150SeniorNotesDue2043Member', window );">4.150% Senior Notes due 2043 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">4.150% Senior Notes due 2043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/43A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A1.750SeniorNotesDue2049Member', window );">1.750% Senior Notes due 2049 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.750% Senior Notes due 2049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A1.625SeniorNotesDue2050Member', window );">1.625% Senior Notes due 2050 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.625% Senior Notes due 2050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_A4.150SeniorNotesDue2053Member', window );">4.150% Senior Notes due 2053 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">4.150% Senior Notes due 2053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A0.000SeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A0.000SeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A2.625SeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A2.625SeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A1.125SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A1.125SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A0.375SeniorNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A0.375SeniorNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A3.000SeniorNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A3.000SeniorNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A3.650SeniorNotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A3.650SeniorNotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A1.625SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A1.625SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A1.000SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A1.000SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A3.125SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A3.125SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A0.750SeniorNotesDue2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A0.750SeniorNotesDue2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A3.375SeniorNotesDue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A3.375SeniorNotesDue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A3.875SeniorNotesDue2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A3.875SeniorNotesDue2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A2.250SeniorNotesDue2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A2.250SeniorNotesDue2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A1.500SeniorNotesDue2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A1.500SeniorNotesDue2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A1.375SeniorNotesDue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A1.375SeniorNotesDue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A4.150SeniorNotesDue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A4.150SeniorNotesDue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A1.750SeniorNotesDue2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A1.750SeniorNotesDue2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A1.625SeniorNotesDue2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A1.625SeniorNotesDue2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_A4.150SeniorNotesDue2053Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_A4.150SeniorNotesDue2053Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>21</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>20</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d34781d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d34781d8k.htm">d34781d8k.htm</File>
    <File>mdt-20250915.xsd</File>
    <File>mdt-20250915_def.xml</File>
    <File>mdt-20250915_lab.xml</File>
    <File>mdt-20250915_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="81">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d34781d8k.htm": {
   "nsprefix": "mdt",
   "nsuri": "http://www.medtronic.com/20250915",
   "dts": {
    "inline": {
     "local": [
      "d34781d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "mdt-20250915.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mdt-20250915_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mdt-20250915_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdt-20250915_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 19,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 21,
   "entityCount": 1,
   "segmentCount": 20,
   "elementCount": 49,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 81
   },
   "report": {
    "R1": {
     "role": "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-09-15_to_2025-09-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d34781d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-09-15_to_2025-09-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d34781d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "mdt_A0.000SeniorNotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A0.000SeniorNotesDue2025Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.000% Senior Notes due 2025 [Member]",
        "terseLabel": "0.000% Senior Notes due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A0.375SeniorNotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A0.375SeniorNotesDue2028Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.375% Senior Notes due 2028 [Member]",
        "terseLabel": "0.375% Senior Notes due 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A0.750SeniorNotesDue2032Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A0.750SeniorNotesDue2032Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.750% Senior Notes due 2032 [Member]",
        "terseLabel": "0.750% Senior Notes due 2032 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A1.000SeniorNotesDue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A1.000SeniorNotesDue2031Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.000% Senior Notes due 2031 [Member]",
        "terseLabel": "1.000% Senior Notes due 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A1.125SeniorNotesDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A1.125SeniorNotesDue2027Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.125% Senior Notes due 2027 [Member]",
        "terseLabel": "1.125% Senior Notes due 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A1.375SeniorNotesDue2040Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A1.375SeniorNotesDue2040Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.375% Senior Notes due 2040 [Member]",
        "terseLabel": "1.375% Senior Notes due 2040 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A1.500SeniorNotesDue2039Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A1.500SeniorNotesDue2039Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.500% Senior Notes due 2039 [Member]",
        "terseLabel": "1.500% Senior Notes due 2039 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A1.625SeniorNotesDue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A1.625SeniorNotesDue2031Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.625% Senior Notes due 2031 [Member]",
        "terseLabel": "1.625% Senior Notes due 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A1.625SeniorNotesDue2050Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A1.625SeniorNotesDue2050Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.625% Senior Notes due 2050 [Member]",
        "terseLabel": "1.625% Senior Notes due 2050 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A1.750SeniorNotesDue2049Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A1.750SeniorNotesDue2049Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.750% Senior Notes due 2049 [Member]",
        "terseLabel": "1.750% Senior Notes due 2049 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A2.250SeniorNotesDue2039Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A2.250SeniorNotesDue2039Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2.250% Senior Notes due 2039 [Member]",
        "terseLabel": "2.250% Senior Notes due 2039 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A2.625SeniorNotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A2.625SeniorNotesDue2025Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2.625% Senior Notes due 2025 [Member]",
        "terseLabel": "2.625% Senior Notes due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A3.000SeniorNotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A3.000SeniorNotesDue2028Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "3.000% Senior Notes due 2028 [Member]",
        "terseLabel": "3.000% Senior Notes due 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A3.125SeniorNotesDue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A3.125SeniorNotesDue2031Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "3.125% Senior Notes due 2031 [Member]",
        "terseLabel": "3.125% Senior Notes due 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A3.375SeniorNotesDue2034Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A3.375SeniorNotesDue2034Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "3.375% Senior Notes due 2034 [Member]",
        "terseLabel": "3.375% Senior Notes due 2034 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A3.650SeniorNotesDue2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A3.650SeniorNotesDue2029Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "3.650% Senior Notes due 2029 [Member]",
        "terseLabel": "3.650% Senior Notes due 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A3.875SeniorNotesDue2036Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A3.875SeniorNotesDue2036Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "3.875% Senior Notes due 2036 [Member]",
        "terseLabel": "3.875% Senior Notes due 2036 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A4.150SeniorNotesDue2043Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A4.150SeniorNotesDue2043Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "4.150% Senior Notes due 2043 [Member]",
        "terseLabel": "4.150% Senior Notes due 2043 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdt_A4.150SeniorNotesDue2053Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medtronic.com/20250915",
     "localname": "A4.150SeniorNotesDue2053Member",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "4.150% Senior Notes due 2053 [Member]",
        "terseLabel": "4.150% Senior Notes due 2053 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary shares, par value $0.0001 per share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "terseLabel": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "terseLabel": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "terseLabel": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.medtronic.com//20250915/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-25-205061-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-205061-xbrl.zip
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M/;3$?C^@^@J,)5A,(Q>V.V\7VTN.H6N?Y4U@/^D>I#HM2W+H(98ZL+)Q(-2
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M?L;QY7)"<^IS8W?DA@;ECG+K;Q?.*^QR431!@C&*EG<4PG2+#>SU6%@J$.F
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M%=H.S53%T6_C,,Q6&M9M+?KU>'Q$ TGU!^5<)IIDZ,#<K8$N],M'R"-R[PC
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M!]O].U7X'CS:?_(8=GDY@CT^ 9,ICM[2Q?P/.+>\*:<KN-"CG:;U3!_'');
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MX04N,*)BL?JR0"I Y!0H)Y=$;%D5T_I2*P6P@&.4$ 5[)[#JY$-TRD]S>>P
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M>\Q/%I<I7=<5/KCFG;%E4 'DZ.#Q3KHKN4W;,YNKGX)O[AT<ZGM]DRMZK71
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MTJ!=^Q@-K<[82O?W*U%T?=M:]*CBQ"2_)W;&APLZ]"Z5PL^Q(44E3 N\AKA
MJ%2Y50>;9655!Y>PH&W7T#XD#FL-RYZ+9X5I@RJ==4'HJ_"J-I&=5@^0+(P=
M8*$U6RKN;J0B[(89X_\X6K)[0U?$P=/#WIMAM\M*0*N@ZIBP$#=8<QP![2E\
MO;R7HE-FM?7"#*,Y];+\?(,HJF9ZR5'S>?*)@O),XDK_B<;#F>\BS?\@=FCZ
M3SH%I6XAPI>XU'.S-<W>LH3KS:]Z6<2*=8I+1,T^7@%3\@IB<U)9)]&G0-^:
M9X[2,=('>.\ZC*2Q2<[V(!G#76>:E=_:\V#5,F9P"2F\<>UZ5FE*1^(B Q%Q
M;@/:ELBYHON:QI([UI"C[F@J^RG5B\XMXJ1T>T2!DF[]P,UES8[ZIBG-A3-Z
ML* X[#UDL+6,E-H :+Z^,=">FSV97&3"HM.<F3IPL=Z,U$28E@Q_Q=%R*1\R
M-SF(<]XX(.N/A .<N-8V+8&V4"7W_-:9:VYSYR#:7]EP"8;#"Q*%$FV5^Z^C
M__&T;Q3]VF$+U1).H18"YS1;.+HV EV1&:-03C.H)@AD_5BD)?#F*7HPOW'D
M+=.TJ Y7<M5^EN:;B9JJ6E9:&4+^I\J"@=^AD/>-'9W4E,E-BM;#EAZI] Z6
M(\-J&K1%F@O;\0F%+1QT15.^8G5(N:TZK5,MH7;\3F5_&/J'HXYKG.(J.^$*
MPO4UYJ2&;_K!GI]Q1-=8I42T+^1%\'.OVJS>QG_WEGUL=W#8>LP=15$@RUAP
M11 !8>.F!R*)W=(467+(1)-QPP%U$\1T$A*XUX6VJ?'I.OI"P]*B+[EP+<&0
M'1T\_7O"%PFQ?>&T3>RI5DM65G5&I? :E,]*L+FU2XVC0B?]=)WEW.KVPAY3
MSG244K,2O+$*_2ZZ0+-JEB;:NS(+SYZJB79%4EAX+%+E&\OPU68R$K:Q6V'/
MU&:- B>A?N".<]M;"R-W'#G9/]@YV]TY[ ^;N(:0MS+C)@G-5QLW>?HM;G)#
M  8=3+P\+(/"OY<P!@NH:@CDE!D;A-R((K<2H@NS>]>[4MAJY2NE'?^5?P\'
MS;R&L"42S;;APH9;'0XC1><) \!727!3%Z9%[]:7<V]E_)>XF?U3=,M@J)MV
MB8KZLM;<D%=;>/1IW;B,R(:N8>&YS00^\-+1KK$"*Z;WX &D7#/4=\6P\7\R
MC:1U(8>I^^+$(5TARP,S-9+A(2@&-O?D#W3[]5L6_06DMV$CP)8W3("VC8"4
MA<%7OH@1P+>3FS?X6&G)()7FY1S2!3)99="FAE:D:?^?K^,^;U"_S+!S5RL.
M8+O?$BITU7;U:^U8RPFM^IR>)SXYGQJ#.<(N.F=ELCB/=L8J-B/RT;FC:$=J
MKI%34H.- Y.:N>K*)S$>'>M@$5U#P:RUJ1Z#@V"_-8@_!;'48J.@"E&OWR5*
MPTAHIDT,LNY15=$O\1()Z12WX2"0MYA*S .9LF/J'8&PX@6R<A^$.12V^#WG
M[JG'!J*(H!_05MN&V6];77U!)V9K_:2'@HS@_PPWYBK.Q[7UFW\=S?PKT6C;
M*:YH2[V%W Y75%RAR%Y1584_OJYRNI$D#0=&E-9JM6;;\Z8> Y5"G1GN7I\Q
M?=3+&9S^TT\KH]!Z8J]LGZY:&:4.[\&[O8;@$K[F7J;%SR0M0=^I/CEC3=A.
MX_EXO.--;5O3)#J"3#!X%Q=ZT13"!#T I%;OM,"?@]'Z\87T%)P@.HVW.;\2
M]2%/9!1V2G=W@BPR*_NIT-AJAM26DPLI.Q?&PW?YF!*XQ"3[<N\M!*X<LP=E
MM>F8X]D1&F.K"H*JX+!BHR1=5D+[]TDRFGZR!OO8' IK7GVJZK6LQNY.I"Z2
MSX[VH/L)V53HT\-I5(5JR:\82?+#MXC([;*ND=)[G904L'!N/G?'$:H*TB9D
MF)CNF0[^!2))!!9:LH <(7 _^H:XK5RE\<29AUH(EZ-4AN&-+](GV/.UFA+V
MWT&HM+ W1 8>('RT,PSO<9L'CW_HB():;LS:DUN[!F>) 33 D.!RJXAS:X95
M#+#"YYAE@JW)*8;A; P&.TRS"BF'0&F4E,GWY*&4":#GNYRQ@"U\A!6A$@JP
ML) 4./\ZH=WU09M[(=MB]@QB0O@M*3^E-5^CKYQ3H"OJDER$"1%33^E'N(+5
MPF%MJ&-]'UU_R>".J.EC^68XAH)67LU]+JO4DVZUT$YTJ6/Q_VP6N\IO5N^S
M6<!K@A>G=@1AO.RH#NXA"E!1H2"/,6V#8GLO3*D98*F$<7/X>UY0TXT$">33
M: 7+?A^[_B?M^D>>^3MIMM*7N^:>(>=HZ-:^,XL3AV[$+%.=&@++IM@/!]>G
M-3>&VKF8KTJVV9B2'LB[IZ7IYYP>#K2=V59R1)M0$V#CFI33XV:5\'IJ:6>Q
M?&7$T3,I2<!NM2!JU-N\J[8)%S3LUV0B]4&+@HMT5BQ8?,\*5($)*"5$Q5"H
MVF,+FRB_X: C4:N%A&CM,0:CR\7MZ#V]L2;@'H)*7%&&W+E8T3-W]%G#P8>M
M-'UOV<M4"FZXX@6-%G[^E+^)5@MHU7(^HR;>K0" 5%*2,A>L)C6-(D+:N$'[
M2:B^.#)-S<D+%OI9EY<!2]Z";8G$2Y@7&1>^2/-D)BU:A8H5DTM,+8I2X3W,
MUD$11J5<(K7"OA5'W;23M*!;\DYN7=#7+"YRQ(U!:$=Z2CN>2 RW.YQ;\%TO
MIMU\F,Z3U"O>4-8Q?%*(ZMA%)W9?Z9CN4W5I);GNZ9+* XET+S9<PD%IOW+T
M7<(TJ@*E#=F4"(XF$,X.5CHDY'%B%JIIB8V[18S5_2?D,\>%8FWFGLYF 6B5
MYX=/THFS<]B:@HQZ#\X8;P!%75L=)[<9"J\YEEL(LJS)"=H9S_(13PD+#0=H
M ^A/'/D%S*U5EL:6,KVM=W_I:D-V,4KJN>>:YFF^N[E[&;C->='_3 <DXWR0
M\*YVM"Y;N^9@P2L0#@[Z<*#2,J'^-N 8S5,+$B:Q#*;O='L7GZ+P1*(5B%^9
M8U"#?$]N^(97=ZLLE*YG!S]SQ]#[0!B0&.F@77C$+Z 3^*6G,W<]$R2D%=05
M%DPY99L<6&8QVP@@=L1;XT:XIZ=5/*P=/"!79T%Y;XC"29IN$JW.Q(>+NBJW
M.A>WI;Y09&AZEH+ A-&*0!O *06GF*'IJ4]I4 4 :N@Y]Q5"^S?F75'1R_*X
M1ZJ$%4[/\U<;UGGV+:QSFV;48ZHQUDX$[1IC>ZUR5?'KIIK%\T_E)W(E2AL/
MNM-9D]Y+;? ) XY1 U&M2H ^#^'F D;Q8',Z5;X)9JK>XV*64-R&M)?^"+62
M^'Y3LKP%*FWJ2F+7T*$=E'FT_WA=C2#G*E/BMZ3<8V6A,QJ0L"6UDIY*7;=,
M8]MO0L<QLT6]IK:([H8UGK2K_$5IH(*:E$JQ.(ZQX?V[]EXR)6/$E]E>UHA)
MJJIB1MP+89875VDDQL;2%JWYFZDNL[,SRKY8AGN8'T7HZ9=];U;]3U7FS4KD
MR,$9'S[DP/\V,-H9$MZ3(<[%VD>";L;4Y1I6"RQNIB*;H+L.?DBYS*#,#-/F
M2$-3%GDVCLHB ;OOG*K5PEP"?K%OYCHB:GS17%W>?:[=:.TV.I:3"Z7?T4<3
M2?KZQ>::'A9H]'IG&"TP#1AU\'@66SU/^E=<*7'VHK=%C1N*&4T7/<3+@  +
M<4L18G-!;DJ<\-'DDONB-/]BHF;D7V5&5%./7[GV$BBS865^$'1LA!G[3LWS
MJ#.YUBP+H\(IL0[L,+4UKR;4K;\F3_5%009UUS]SKW<6K D,_HSCW*+"UC_G
M/IJ0TKTA(1*#%""'2^&+!J7)BGLK>'\+:XQ?<96,.^YZ<G0*'5MB,8QF%!IS
MX%R>H$S)57 1]'Y4S>X]50F>2+HH&66^=89;#PQME":Q7:4U SI0/Y[BV4']
M>G(BQ^8>YO"$+2>USKF)O5$2RJ!MB+GVZ'!B3,1<-QJ\"QT?![BQ4B0QF@#"
MB<RE>O:E'K>#*\Q&<$;M8]X3EG'\6B*U&3&2,BD,9Q?XNK9\MF&[5SWTQ6Q6
M7)*H>K??.3;5C^MV[\N2QY@DF(=Q/(\H:EXLL-=T6DJ;QN+&D&@?=W*@BIB-
MY;Q8A_V..RP+5RBQH=2HU[1T8]')^+)4SV_9KMUZW@(2;5ECSN_SP0"$)L]
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M<Z5-A".((\H'X/T_L85.]U8+"-N 0XW>I#1VUA&_&ZM?3,/A(&2E[HB Q:
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MC)"DNLAIKZRKQ;%^0O-EO6274^S50H44#.UR97M4]VT_*D[445)!1&$W0]C
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M<#AR90]?N">;S^M:PA%&>68.@ *@,^X3#(W!&67XX>[#7W'G4,H;;D/MT1S
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MA;SK/?J??KVLVO(O4$L! A0#%     @ )X4P6S6IZ,H)&   U>D   T
M         ( !     &0S-#<X,60X:RYH=&U02P$"% ,4    "  GA3!;P&5K
M=-^6   -:0, #P              @ $T&   9#,T-S@Q9&5X,3$N:'1M4$L!
M A0#%     @ )X4P6\-:=2!G!   ?QP  !               ( !0*\  &UD
M="TR,#(U,#DQ-2YX<V102P$"% ,4    "  GA3!;9FEW SP'  !.40  %
M            @ '5LP  ;61T+3(P,C4P.3$U7V1E9BYX;6Q02P$"% ,4
M"  GA3!;0?I=?\\*   &D0  %               @ %#NP  ;61T+3(P,C4P
M.3$U7VQA8BYX;6Q02P$"% ,4    "  GA3!;0^^:#>8&  ##6   %
M        @ %$Q@  ;61T+3(P,C4P.3$U7W!R92YX;6Q02P4&      8 !@!\
) 0  7,T

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d34781d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdt="http://www.medtronic.com/20250915"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mdt-20250915.xsd" xlink:type="simple"/>
    <context id="duration_2025-09-15_to_2025-09-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A0.000SeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A2.625SeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.125SeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A0.375SeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.000SeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.650SeniorNotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.625SeniorNotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.000SeniorNotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.125SeniorNotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A0.750SeniorNotesDue2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.375SeniorNotesDue2034Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A3.875SeniorNotesDue2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A2.250SeniorNotesDue2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.500SeniorNotesDue2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.375SeniorNotesDue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A4.150SeniorNotesDue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.750SeniorNotesDue2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A1.625SeniorNotesDue2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:A4.150SeniorNotesDue2053Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-09-15_to_2025-09-15"
      id="Hidden_dei_EntityCentralIndexKey_duration_2025-09-15_to_2025-09-15">0001613103</dei:EntityCentralIndexKey>
    <dei:EntityAddressPostalZipCode
      contextRef="duration_2025-09-15_to_2025-09-15"
      id="Hidden_dei_EntityAddressPostalZipCode_duration_2025-09-15_to_2025-09-15">H91 VY19</dei:EntityAddressPostalZipCode>
    <dei:AmendmentFlag
      contextRef="duration_2025-09-15_to_2025-09-15"
      id="Hidden_dei_AmendmentFlag_duration_2025-09-15_to_2025-09-15">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2025-09-15_to_2025-09-15" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-09-15_to_2025-09-15" id="Fact_0">2025-09-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-557">Medtronic plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-558">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-559">1-36820</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-560">98-1183488</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-561">Building Two</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-562">Parkmore Business Park West</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-563">Galway</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-564">IE</dei:EntityAddressCountry>
    <dei:CountryRegion contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-565">353</dei:CountryRegion>
    <dei:CityAreaCode contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-566">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-567">438-1700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-568">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-569">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-570">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-571">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-572">Ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-573">MDT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-574">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member"
      id="ixv-575">0.000% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member"
      id="ixv-576">MDT/25A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.000SeniorNotesDue2025Member"
      id="ixv-577">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member"
      id="ixv-578">2.625% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member"
      id="ixv-579">MDT/25B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.625SeniorNotesDue2025Member"
      id="ixv-580">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member"
      id="ixv-581">1.125% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member"
      id="ixv-582">MDT/27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.125SeniorNotesDue2027Member"
      id="ixv-583">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member"
      id="ixv-584">0.375% Senior Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member"
      id="ixv-585">MDT/28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.375SeniorNotesDue2028Member"
      id="ixv-586">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member"
      id="ixv-587">3.000% Senior Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member"
      id="ixv-588">MDT/28A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.000SeniorNotesDue2028Member"
      id="ixv-589">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member"
      id="ixv-590">3.650% Senior Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member"
      id="ixv-591">MDT/29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.650SeniorNotesDue2029Member"
      id="ixv-592">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member"
      id="ixv-593">1.625% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member"
      id="ixv-594">MDT/31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2031Member"
      id="ixv-595">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member"
      id="ixv-596">1.000% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member"
      id="ixv-597">MDT/31A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.000SeniorNotesDue2031Member"
      id="ixv-598">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member"
      id="ixv-599">3.125% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member"
      id="ixv-600">MDT/31B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.125SeniorNotesDue2031Member"
      id="ixv-601">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member"
      id="ixv-602">0.750% Senior Notes due 2032</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member"
      id="ixv-603">MDT/32</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A0.750SeniorNotesDue2032Member"
      id="ixv-604">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member"
      id="ixv-605">3.375% Senior Notes due 2034</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member"
      id="ixv-606">MDT/34</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.375SeniorNotesDue2034Member"
      id="ixv-607">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member"
      id="ixv-608">3.875% Senior Notes due 2036</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member"
      id="ixv-609">MDT/36</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A3.875SeniorNotesDue2036Member"
      id="ixv-610">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member"
      id="ixv-611">2.250% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member"
      id="ixv-612">MDT/39A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A2.250SeniorNotesDue2039Member"
      id="ixv-613">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member"
      id="ixv-614">1.500% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member"
      id="ixv-615">MDT/39B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.500SeniorNotesDue2039Member"
      id="ixv-616">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member"
      id="ixv-617">1.375% Senior Notes due 2040</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member"
      id="ixv-618">MDT/40A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.375SeniorNotesDue2040Member"
      id="ixv-619">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member"
      id="ixv-620">4.150% Senior Notes due 2043</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member"
      id="ixv-621">MDT/43A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2043Member"
      id="ixv-622">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member"
      id="ixv-623">1.750% Senior Notes due 2049</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member"
      id="ixv-624">MDT/49</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.750SeniorNotesDue2049Member"
      id="ixv-625">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member"
      id="ixv-626">1.625% Senior Notes due 2050</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member"
      id="ixv-627">MDT/50</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A1.625SeniorNotesDue2050Member"
      id="ixv-628">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member"
      id="ixv-629">4.150% Senior Notes due 2053</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member"
      id="ixv-630">MDT/53</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-15_to_2025-09-15_us-gaap-StatementClassOfStockAxis_mdt-A4.150SeniorNotesDue2053Member"
      id="ixv-631">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-09-15_to_2025-09-15" id="ixv-632">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
